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Lost natural teeth can be replaced with a variety of dental prosthesis, dental implants being one 
of the most successful methods. Contemporary dental implants are shaped similar to the root of a 
natural tooth and are almost exclusively made from commercially pure titanium or titanium 
alloys. A typical root-form endosseous implant consists of a titanium screw with a roughened or 
smooth surface. Endosseous dental implants are installed into the alveolar or basal bone by a 
single stage or two stage surgical procedures [1]. The healing process after dental implant 
placement results in osseointegration, which is the formation of a direct interface between an 
implant and bone without intervening soft tissue. Osseointegration was discovered and first 
described in 1983 by P.I. Brånemark [2].  
Due to high success rates [3], the use of titanium dental implants has increased 
significantly during the past three decades. Success of an implant has been defined as implant 
and fixed prosthesis present in the mouth in the absence of biological and/or technical 
complications during the observation period [4]. However, failure of dental implants also occur 
and often leads to its removal. Failure of dental implant can occur due to the inability of tissues 
to establish osseointegration prior to the placement of dental prosthesis and is suggested to occur 
due to interference with the healing process [5]. Possible causes include lack of adequate bone 
volume, smoking, surgical trauma, lack of primary stability, intra-osseous infection and bacterial 
contamination of the recipient site [6, 7]. Failures of dental implants occurring after occlusal 
loading are suggested to occur due to the breakdown of the already established osseointegration 
[5, 8]. Breakdown of the established osseointegration may occur due to peri-implantitis and/or 
mechanical overload [6, 9, 10]. Depending on intraoral loading time, failure rates of 7.7 to 17 % 
have been reported for different implant systems [5, 11].  
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Peri-implantitis 
Definition, diagnosis and prevalence 
The term peri-implantitis was introduced more than two decades ago to encompass infectious 
pathological conditions affecting dental implant [12-14]. According to the consensus report from 
the 7th European Workshop on Periodontology [15], in peri-implant mucositis, inflammatory 
response is limited to the soft tissues surrounding a functioning dental implant, whereas 
inflammatory response in peri-implantitis also results in loss of peri-implant marginal bone. 
Continued inflammation and bone loss around dental implant can lead to mobility and loss of the 
implant. Diagnosis of peri-implantitis is made similar to periodontitis and involves measuring 
clinical parameters such as peri-implant pocket depth (PPD), bleeding on probing (BoP), plaque 
index (PI), peri-implant loss of gingival attachment, suppuration and mobility [16]. Radiographic 
assessment of peri-implant bone loss also forms part of the current diagnostic tools for peri-
implantitis. There is considerable variation in the reported prevalence of peri-implantitis in 
different studies. According to a review by Zitzmann and Berglundh [17], 28 to ≥ 56 % of the 
participants and 12 to 43% of the implants could be affected by peri-implantitis. Different 
disease definitions, follow-up periods or implant systems studied, could lead to such variations in 
the results of different studies. In a recent systematic review [18], peri-implantitis has been 
reported to occur in up to 18.8 % of patients and 9.6 % of implants. In terms of late implant 
failures, results of meta-analyses suggest that peri-implantitis accounts for 10-50% of failed 
implants after one year of loading [5, 19]. 
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Etiology and microbiology 
The etiology of peri-implantitis is multi-factorial but microorganisms play a central role in the 
development and progression of peri-implantitis [20, 21]. Implants surrounded by tissue free 
from clinical inflammation demonstrate microbiota associated with periodontal health which is 
dominated by Gram-positive facultative cocci and rods [22-24]. A complex subgingival 
microbiota is established during the tissue breakdown in peri-implantitis which is dominated by 
Gram-negative anaerobes and closely resembles the microbiota found in chronic adult 
periodontitis [25-27]. Oral bacteria that are strongly associated with peri-implantitis include 
Porphyromonas gingivalis, Prevotella intermedia/Prevotella nigrescens, Tannerella forsythia, 
Treponema denticola and Aggregatibacter actinomycetemcomitans [28]. However, several 
studies have found microorganisms not primarily associated with periodontitis such as 
Staphylococcus species, Candida species and Enterics in peri-implantitis lesions [22, 26, 29-33]. 
Interestingly, Staphylococci are also frequently isolated from infections of medically used 
metallic biomaterials other than dental implants [34, 35]. In vitro studies have shown an affinity 
of S. aureus to titanium surfaces in particular [36] and  studies support association of S. aureus 
with therapy resistant cases of peri-implantitis [37-40]. However, importance of such reports for 
the pathogenesis of peri-implantitis needs further investigations. More recent studies, while 
maintaining the association of Gram-negative anaerobic microorganisms with peri-implantitis, 
reveal new microbial signatures that might be uniquely associated with peri-implantitis [41, 42]. 
Using 16S rRNA gene clone library technique for bacterial detection, it  has been suggested that 
microbiota around implants in peri-implantitis is more complex when compared to periodontitis 
[41]. Another study has recently compared the microbiota around healthy implants, healthy teeth, 
periodontitis and peri-implantitis using 16S pyrosequencing [43]. This study suggested the 
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association of some previously unsuspected microbial species such as Streptococcus mutans and 
Butryvibrio fibrisolvens with peri-implantitis. However, in order to establish an association of 
these microorganisms with peri-implantitis, studies with a larger sample size are needed. 
Besides bacteria, a history of periodontitis, smoking, an aberrant host response to 
microbial pathogens and poor oral hygiene are the most important known risk factors for 
developing peri-implantitis [44, 45]. Several systematic reviews have been published on the 
association of past history of periodontitis and development of peri-implantitis [46-50]. There is 
considerable heterogeneity in the study design, length of follow up, definition of patient 
population and outcome measures among the studies identified in these reviews. However, from 
these reviews, it can be concluded that past history of periodontitis is a risk factor for peri-
implantitis [45]. Smoking is a known risk factor for several chronic conditions and peri-
implantitis is no exception. Effects of smoking on implant have been systematically reviewed by 
Strietzel et al. [51]. Smoking has been associated with significantly increased inflammation 
related clinical parameters [52, 53], peri-implant bone loss [53, 54] and peri-implantitis [55]. In 
addition to the above mentioned established risk factors, preliminary data supports genetic 
susceptibility to increase the risk for developing peri-implantitis [56]. A recent review has 
concluded that interleukin (IL)-1 gene polymorphisms (IL1A -889 and ILB +3954 genotype) in 
combination with smoking increases the risk for peri-implant bone loss in peri-implantitis [57]. 
Association of viruses such as human cytomegalovirus (HCMV) -2 and Epstein-Barr virus 
(EBV) -1 with peri-implantitis has also been reported [58].  
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Peri-implantitis lesions 
Although peri-implantitis shares some characteristics with periodontitis, inflammatory lesions in 
peri-implantitis are different in certain aspects compared to periodontitis lesions [59]. 
Experimental studies on the tissue response to established biofilms have reported more 
pronounced inflammation around implants compared to natural teeth (figure 1, A&B)[60]. Peri-
implantitis lesions tend to be more aggressive in nature and animal studies have revealed that 
peri-implantitis lesions extend more apically compared to periodontitis lesions [15]. Moreover, 
differences in the composition of inflammatory cell infiltrate have been found between peri-
implantitis and periodontitis lesions [15]. In a study by Gualini & Berglundh [61], elastase-
producing cells were found to be more common in peri-implantitis lesions, possibly indicating a 
more acute type of infection than periodontitis. Experimental animal models have demonstrated 
more pronounced and persistent bone loss around implants compared to natural teeth [62-64]. In 
addition, the circumferential pattern of bone loss seen in peri-implantitis is different from the 
often localized horizontal bone loss seen in periodontitis (figure 2, A&B). It has been suggested 
that the different surface properties of dental implants may favor colonization of specific 
microorganisms and thus may partly account for the differences seen between peri-implantitis 
and periodontitis lesions [65-67]. The absence of a periodontal ligament around implant, a low 
degree of vascularization and a higher collagen fiber to fibroblast ratio in comparison to the 
tooth, may all have an effect on the pattern and rate of bone loss in peri-implantitis [63, 68, 69]. 
Nevertheless, mechanisms behind the different tissue responses seen in peri-implantitis lesions 
are not known and needs further investigations.  
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Figure 1 
A. Peri-implantitis lesion  B. Periodontitis lesion 
 
Photos courtesy David Anssari Moin, department of oral function and restorative dentistry, ACTA.   
 
 
Figure 2 
A. Circumferential bone loss in peri-implantitis B. Localized bone loss seen in periodontitis 
  
Photos courtesy David Anssari Moin, department of oral function and restorative dentistry/department of 
periodontology, ACTA.   
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Clinical management 
Clinical management of peri-implantitis aims to eliminate plaque and calculus, decontaminate 
implant surface and regenerate lost tissue. Peri-implantitis is clinically managed in a similar way 
to periodontitis [70]. However, a systematic review by Esposito et al. [71] concluded that there is 
little evidence to support such an approach. For peri-implantitis, the effectiveness of a treatment 
protocol including surgical access, implant surface decontamination and systemic antimicrobials 
followed by a strict postoperative protocol has been shown recently [72]. Conservative non-
surgical treatment for peri-implantitis includes mechanical debridement by scaling and root 
planning combined with local or systemic antibacterial agents. Use of lasers has also been 
reported for non-surgical treatment of peri-implantitis [73]. However, available evidence for the 
effectiveness of non-surgical treatment protocols for peri-implantitis is insufficient [74]. There is 
a lack of consensus on evidence based treatment modalities for peri-implantitis [75]. Therefore, 
more studies are needed to evaluate the clinical and microbiological outcomes of non-surgical 
treatment modalities for peri-implantitis. Moreover, interaction of oral bacteria associated with 
peri-implantitis, such as P. gingivalis, with host cells is of utmost importance to better 
understand the pathogenesis of peri-implantitis and devise better treatment strategies.   
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Porphyromonas gingivalis 
Porphyromonas gingivalis is strongly associated with disease initiation and progression in peri-
implantitis [76]. It is a black-pigmented, Gram-negative, anaerobic, rod shaped bacterium. It is 
one of the most extensively studied oral bacterium. Therefore it is a valuable model organism to 
study the in vitro host-bacterial interaction in peri-implantitis. Through its varied virulence 
factors (figure 3), P. gingivalis can evade recognition by innate immune system, directly invade 
host cells, avoid killing by complement, corrupt the innate immunity in a way to maximize 
chances for its survival and may favorably alter the environment for other opportunistic 
pathogens in periodontal diseases [77]. Some of the most important virulence factors associated 
with P. gingivalis are described below; 
P. gingivalis proteinases 
P. gingivalis produces a variety of proteinases [78-80] which can degrade host proteins. The 
pathological role of proteinases produced by P. gingivalis has been recently reviewed [81]. 
These proteinases provide P. gingivalis with the necessary nutrition by breaking down host 
proteins [82]. The activity of trypsin-like proteinses (also called gingipains) produced by P. 
gingivalis, show a close relationship with P. gingivalis virulence [83]. P. gingivalis gingipains 
can also breakdown components of the host immune system and thus play an important role in 
modulation of host immune responses [84]. In addition, some P. gingivalis gingipains can play a 
role in its attachment to the host extracellular matrix such as collagen, thereby facilitating matrix 
breakdown [84]. P. gingivalis gingipains also play a role in  biofilm formation with other 
bacterial species [85].  
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Fimbriae 
P. gingivalis is also equipped with major and minor fimbriae which are thread-like proteins 
anchored in its outer membrane. Fimbriae have multiple functions and their importance has been 
shown for adherence and invasion of host cells [86, 87]. Specific P. gingivalis fimbriae can also 
play an immunomodulatory role by the release of cytokines from host cells via CD14 receptors 
and Toll-like receptors (TLR), like TLR-2 and -4 [88]. P. gingivalis fimbriae have been shown to 
play a role in periodontal bone resorption in animal models [89, 90].  
Lipopolysaccharide 
Another important virulence factor of P. gingivalis is its lipopolysaccharide (LPS), which is a 
major component of Gram-negative bacteria and is important for their structural integrity. LPS is 
a strong stimulator of cytokines in a variety of host cell types and has been reported to induce 
bone resorption [91, 92]. Upon exposure to P. gingivalis LPS, host cells such as gingival 
fibroblasts produce a range of pro-inflammatory cytokines including IL-1, IL-6, IL-8 and tumor 
necrosis factor (TNF)-α [93]. It has been suggested that binding of P. gingivalis LPS to TLRs 
rather than to CD14 on fibroblasts activates these cells to produce pro-inflammatory cytokines 
[93]. Interestingly, P. gingivalis LPS also suppresses the innate immune response via TLR-
signaling [94]. It has been proposed that these opposing immune responses may be due to the 
heterogeneity in P. gingivalis LPS structure, resulting in the dysregulation of overall immune 
response commonly seen in periodontal diseases [95].  
Capsular polysaccharide 
Another major virulence factor of P. gingivalis is its polysaccharide capsule. Capsular 
polysaccharide (CPS) produced by P. gingivalis surrounds the bacterial cell and has antigenic 
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properties. On the basis of antigenic properties of its capsule, seven encapsulated (K1-K7) and 
one non-encapsulated (K-) serotypes of P. gingivalis have been described [96, 97]. P. gingivalis 
strains HG91 (originally strain 381) and ATCC 33277 are considered K-antigen negative as they 
lack a capsular-specific antibody response and strain HG91 has no capsular-polysaccharide layer 
as determined by electron microscopy and phase contrast analysis [97-99]. A number of studies 
have indicated that P. gingivalis CPS contributes significantly to its virulence [100-102]. 
Immunization with P. gingivalis CPS has been shown to protect mice from P. gingivalis-elicited 
bone loss [103]. CPS has been found to play a role in the evasion of host immune response by 
other microorganisms [104-106] and a similar function for P. gingivalis CPS has also been 
suggested [107]. Compared to non-encapsulated strains, encapsulated P. gingivalis strains are 
more virulent in an animal model (Laine et al. 1998), resistant to phagocytosis by 
polymorphonuclear cells [108] and their ability to activate the alternative complement pathway is 
reduced [100, 102, 108].  P. gingivalis CPS also decreases the ability of periodontal ligament 
fibroblasts to attach to the root surface of teeth [109]. Invasion of gingival fibroblast by P. 
gingivalis has been reported earlier [110] but it is not known whether P. gingivalis capsule 
affects its ability to invade host cells.  
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Figure 3 
 
Schematic diagram of P. gingivalis’ cell envelope with its major virulence factors [111] 
 
Host-bacterial interaction in peri-implantitis 
Adhesion and invasion 
Oral bacteria associated with peri-implantitis colonize peri-implant sulcus/pocket by adhering to 
implant surface and various host cell-types. Adhesion to host cells is an important first step for 
the establishment of a successful infection. P. gingivalis can adhere to epithelial cells, 
endothelial cells and fibroblasts in the peri-implant connective tissues and the number of P. 
gingivalis adhering to periodontal epithelium has been shown to correlate strongly with the 
severity of inflammation in periodontal diseases [112]. Adhesion may proceed to invasion of the 
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host cells and thereby offer protection to P. gingivalis from external pressures such as host 
immune factors and antibiotics [110, 113-115]. Once inside the host cell, P. gingivalis can block 
apoptosis by up-regulating anti-apoptotic factors and down-regulating pro-apoptotic factors [116, 
117]. As a result, P. gingivalis can persist and multiply within host cells and possibly play a role 
in recurrence of the infection in periodontal diseases [118].  
Differences in the adhesion capacity of laboratory and clinical strains of P. gingivalis 
have been reported [119-123]. Host-cell adhesion and invasion of P. gingivalis depend on 
multiple factors. P. gingivalis fimbriae and gingipains are important for adhesion and invasion of 
host cells, and differences in the adherence and invasion capacity of different fimbrial strains of 
P. gingivalis have been shown [87, 124, 125]. In addition, surface hydrophobicity of the P. 
gingivalis strain is also an important determinant of its adherence to host cells [119]. CPS of P. 
gingivalis has been shown to decrease its ability to adhere to pocket epithelium in vitro [126]. 
However, it is not known whether the capsule also alters the ability of P. gingivalis to invade 
host cells. Furthermore, susceptibility of internalized P. gingivalis to antibiotics has not been 
studied.  
Modulation of host immune response 
The majority of implant complications including peri-implantitis tend to concentrate in a 
relatively smaller group of patients [11]. Therefore susceptibility of the host is an important 
determinant of the development of peri-implantitis. Bacterial interaction with host cells result in 
the release of certain inflammatory mediators and growth factors with the aim to eliminate the 
invading microorganisms and to repair the resulting tissue damage. To a larger extent, 
progression of tissue damage in peri-implantitis depends on the presence and activity of certain 
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bacteria and high local production of pro-inflammatory mediators, matrix metalloproteinases 
(MMPs) and prostanoids, accompanied by low local production of inhibitors of inflammation 
and growth factors [127-129]. These inflammatory mediators play an important role in peri-
implant bone resorption by promoting osteoclastogenesis and subsequently activating the 
differentiated osteoclasts [130]. In addition, pro-inflammatory mediators such as IL-1β and TNF-
α also induce the release of prostaglandin (PGE)-2 from monocytes and fibroblasts [131], 
thereby further enhancing tissue damage. An aberrant host response resulting in peri-implant 
tissue destruction has been reported for peri-implantitis [132-134].  
As peri-implantitis is a site specific infection, local production of pro-inflammatory 
mediators in response to oral bacteria is important since these mediators increase the tissue 
perfusion and attract immune-competent cells such as monocytes/macrophages, lymphocytes and 
neutrophils. Immune cells from the circulation further enhance the inflammatory reaction and 
local tissue damage. Non-circulating cells such as gingival fibroblasts and gingival epithelial 
cells [113] are known to produce inflammatory mediators in response to microbial challenge. 
Due to their slower turnover rate compared to epithelial cells, fibroblasts can play an important 
role in the chronic inflammation associated with peri-implantitis. Studies reporting on the role of 
fibroblasts in the pathogenesis of peri-implantitis are limited [135, 136]. Interaction of oral 
fibroblasts with P. gingivalis has been shown to up-regulate production of inflammatory 
mediators including IL-1β, IL-6, IL-8 [137], monocyte chemotactic protein - (MCP) - 1[138] and 
matrix metalloproteinases (MMPs) [139]. In addition to extracellular matrix, MMPs can also 
cleave cytokines into smaller fragments and thus may activate or deactivate them [140]. Tissue 
inhibitors of metalloproteinases (TIMPs) tend to restrict matrix breakdown by MMPs [141] 
while members of transforming growth factor-beta (TGFβ)  protein family regulate fibrogenesis 
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as well as vascular homeostasis [142]. MMPs are involved in physiological tissue remodeling in 
health but imbalances in the levels of MMPs and their inhibitors can result in breakdown of 
extracellular matrix.  
Role of the implant material in peri-implantitis 
Several types of synthetic biomaterials have been used for dental implants such as metals 
(titanium) and alloys (titanium-aluminum-vanadium alloy), ceramics (aluminum oxide, 
hydroxylapatite) and carbon, and polymers, mainly polymethylmethacrylate (PMMA) [143]. 
Dental implants used in current clinical practice are almost exclusively made from commercially 
pure titanium or its alloys. Furthermore, titanium dental implants can be coated with 
hydroxylapatite to produce a bio-active surface which promotes and induces a direct bond 
between the implant and bone tissue surrounding it [144].  
Titanium (Ti) is considered the material of choice for dental implants due to its corrosion 
resistance and biocompatibility with and within living tissues [145]. However, corrosion 
resistance of Ti can decrease in oral environment [146] and wear debris in the form of titanium 
particles have been detected in peri-implant soft tissues [147, 148]. In a recent study [149], 
higher concentration of Ti particles were found in the peri-implant tissues of diseased implants 
when compared to healthy dental implants. There is an increasing interest in the interaction of Ti 
wear debris with host cells across different fields of study such as dental implantology and 
orthopedics. Ti is known to elicit inflammatory responses from human cells [150] and may also 
play a role in peri-implant bone resorption through facilitation of osteoclast differentiation [151]. 
In addition inhibition of bone formation by macrophage-like cells exposed to Ti particles has 
been reported [152]. In a clinical study, Nowzari et. al. [153] found elevated levels of pro-
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inflammatory cytokines in the peri-implant sulcular fluid of clinically healthy dental implants.  
Furthermore, allergy to Ti has also been reported and may play a role in the pathogenesis of peri-
implantitis [154].  
A synergistic effect of Ti and bacterial-LPS on the pro-inflammatory responses of host 
cells has been described [155, 156]. However, since bacteria and implant material act in concert, 
affecting the host cells in the in vivo situation; it is important to study the interaction of host cells 
with implant-biomaterial and pathogenic microorganisms, together. Therefore, the current thesis 
also aims to study the effects of Ti and P. gingivalis on the inflammatory responses of peri-
implant fibroblasts from peri-implantitis patients. 
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Aims and thesis outline 
Studies on the interaction between host cells and bacteria in the etiopathogenesis of peri-
implantitis are limited. Therefore, the general aim of this thesis was to study interactions between 
P. gingivalis and fibroblasts in peri-implantitis. In addition, pro-inflammatory responses in 
fibroblasts to titanium particles and effects of non-surgical peri-implantitis treatment on the 
clinical and microbiological parameters were also studied.  
In Chapter 2 the ability of P. gingivalis to invade gingival fibroblasts and the role of P. 
gingivalis capsule in invasion of gingival fibroblasts was evaluated. Furthermore, survival of 
internalized P. gingivalis after in vitro antibiotic treatment was studied.   
 The host response is an important factor in peri-implantitis. Fibroblasts from peri-
implant lesions may differ in their response to microbial challenge compared to fibroblasts from 
periodontitis lesions and healthy donors. Therefore, the aim of Chapter 3 was to compare the 
pro-inflammatory and matrix-degrading responses of fibroblasts from periodontally healthy 
controls, peri-implantitis, and periodontitis lesions to an in vitro challenge with Porphyromonas 
gingivalis. In addition, the potential role of fibroblast from peri-implantitis lesions in sustaining 
inflammation in peri-implantitis was also studied. 
Titanium particles can be detected in the peri-implant tissues of individuals with dental 
titanium implants and these released titanium particles are capable of inducing immune 
responses in human cells. In Chapter 4 we aimed to determine influence of titanium micro-
particles on the in vitro inflammatory responses of peri-implant granulation tissue fibroblasts to 
viable P. gingivalis.  
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Literature on the non-surgical treatment of peri-implantitis is scarce. Therefore, in 
Chapter 5 the effects of non-surgical peri-implantitis treatment with or without antibiotics on 
clinical, microbiological and radiographic parameters of peri-implantitis were evaluated.  
In Chapter 6, results of chapters 2-5 of this thesis are reviewed and discussed. Moreover, the 
potential clinical implications of our results and directions for relevant future research have been 
suggested.  
Chapter 7 reiterates a short summary of the results and their clinical implications.  
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Abstract 
Background: Porphyromonas gingivalis is a Gram-negative, anaerobic bacterium involved in 
periodontitis and peri-implantitis that can invade and survive inside host cells in vitro. P. 
gingivalis can invade human gingival fibroblasts (GF) but no data is available about the role of 
P. gingivalis’ capsule in GF invasion. In the current study we aimed to determine the ability of 
three strains of P. gingivalis (encapsulated wild type W83, non-encapsulated HG91 and the non-
encapsulated insertional isogenic knockout mutant of W83, ΔEpsC) to invade GF and the ability 
of internalized P. gingivalis to survive in vitro antibiotic treatment. 
 Methods: The ability of P. gingivalis strains to invade GF was tested using an antibiotic 
protection assay at multiplicity of infection (MOI) 100 and 1000. The survival of internalized P. 
gingivalis cells was further analyzed by subsequent in vitro treatment with either metronidazole 
or amoxicillin alone or a combination of metronidazole and amoxicillin and anaerobic culture 
viability counts.   
Results: All strains of P. gingivalis used in this study were able to invade GFs. The non-
encapsulated mutant of W83 (ΔEpsC mutant) was significantly more invasive than the wild type 
W83 at MOI 100 (p-value = 0.025) and MOI 1000 (p-value = 0.038). Furthermore, internalized 
P. gingivalis was able to resist in vitro antibiotic treatment.  
Conclusion: As demonstrated by the differences in invasion efficiencies of P. gingivalis strain 
W83 and its isogenic mutant ΔEpsC, the capsule of P. gingivalis makes it less efficient in 
invading gingival fibroblasts. Moreover, internalized P. gingivalis can survive antibiotic 
treatment in vitro.  
Key words Periodontitis, Mechanism of antibiotic resistance, Internalization, Capsule, 
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Introduction 
Porphyromonas gingivalis is a Gram-negative, anaerobic, non-motile rod shaped bacterium 
found in sub-gingival plaque that has been associated with chronic adult periodontitis [1] and 
peri-implantitis [2]. P. gingivalis is equipped with a broad array of virulence factors [3] 
potentially involved in tissue colonization and destruction. P. gingivalis capsule is an important 
virulence factor and it has been shown that encapsulated P. gingivalis strains are more virulent 
than non-encapsulated strains in a mouse model [4], non-encapsulated strains adhere more to 
epithelial cells compared to encapsulated strains [5] and the capsule may be immunosuppressive 
for human gingival fibroblasts (GF) in vitro [6]. On the basis of capsular polysaccharides, seven 
capsular (K1-K7) and a non-capsular serotype of P. gingivalis have been described previously 
[7,8].  
Invasion  into host cells is one of the multiple ways in which pathogens interact with the 
host immunity [9]. P. gingivalis has been shown to invade into a variety of host cells in several 
in vitro studies [10-13], and to persist and multiply within the epithelial cells [14]. The capsule 
may impede the process of invading host cells by P. gingivalis, as partial dissolution of P. 
gingivalis capsule with amyloglucosidase has been shown to increase the invasion efficiency of 
P. gingivalis into endothelial cells [12]. 
Systemic metronidazole is most commonly used either alone or in combination with 
amoxicillin as an adjunct to periodontitis and peri-implantititis treatment [15]. Recurrence of 
periodontitis may still be a problem in some patients after the use of systemic antibiotics, 
probably due to a hampered eradication of periodontal pathogens such as P. gingivalis [16]. 
Intracellular presence of P. gingivalis in epithelial cells collected from patients after systemic 
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antibiotic treatment has been reported [17], and may reflect inadequacy of conventional 
antibiotics to eliminate internalized P. gingivalis.  
Fibroblasts are the most abundant stromal cell type in the connective tissue of gingiva 
[18] and important cells in the pathogenesis of periodontitis [19]. P. gingivalis has been shown to 
penetrate multilayered epithelial cells and reach the underlying connective tissue in an in vitro 
model [20] which is also consistent with in vivo observations [21]. To the best of our knowledge, 
the role of P. gingivalis capsule in invading GF is not known and we hypothesize that the non-
encapsulated P. gingivalis may be internalized more efficiently into GFs and survive antibiotic 
treatment inside GF. Therefore, the aim of our current study was to evaluate the effects of P. 
gingivalis capsule on its ability to invade GF and to investigate the in vitro effectiveness of 
metronidazole, amoxicillin and combination of metronidazole and amoxicillin, on intracellular P. 
gingivalis. 
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Material and methods 
Bacterial strains 
P. gingivalis strains W83 (K1 serotype), HG91 (K- serotype) and an isogenic non-encapsulated 
knockout mutant of W83 (ΔEpsC mutant, K- serotype), were grown anaerobically (80% N2, 10% 
H2, and at 10%CO2 at 37˚C) until log growth phase in brain-heart infusion broth (BHI, BactoTM 
Brain Heart Infusion, Becton, Dickinson and Company, USA) enriched with hemin (5 μg/ml) 
and menadione (1 μg/ml). Purity of the cultures was checked by Gram-staining. The ΔEpsC 
mutant is an insertional isogenic W83 knockout in the epimerase-coding gene EpsC that is 
located at the end of the capsular biosynthesis locus [6]. 
P. gingivalis were harvested by centrifugation at 5000 rpm, for 15 minutes. Bacterial 
pellets were washed twice in sterile phosphate-buffered saline (PBS) and resuspended in DMEM 
containing 10% fetal bovine serum (FBS, HyClone, Logan, UT, USA) without antibiotics. The 
optical density (OD690) of the fluid bacterial culture in BHI was measured at 690 nm wavelength. 
An OD690 = 0.8 corresponding to 2*109 CFUs/ml on bacterial growth curves for different P. 
gingivalis strains (data not shown), was used to establish the number of colony-forming units 
(CFUs) and infect GFs.  
Human gingival fibroblasts (GF) 
Gingival fibroblasts isolated from an extracted third molar of a 62 years old, periodontally 
healthy, non-smoking female during a previous study [22] were used. The donor had given a 
written informed consent and the study was approved by the VUmc (Vrije Universiteit medical 
centre) medical ethical committee. Briefly, the tissue sample was taken by collecting the free 
gingiva around the tooth. The tissue sample was washed and maintained as explants in 
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Dulbecco’s modified Eagle medium (DMEM; 4.5 g/L glucose + L-glutamine + pyruvate; 
Invitrogen/Gibco Paisley, UK) supplemented with 10% fetal bovine serum (FBS; 
Invitrogen/Gibco, Paisley, Scotland, UK) and 2% antibiotics/antimycotics (PSF; 100 U/ml of 
penicillin, 100 μg/ml streptomycin and 250 ng/ml of amphotericin B; Sigma, St Louis, Mo, 
USA) in a humidified environment with 5% CO2 at 37˚C until growth of fibroblasts was 
observed under the microscope. These fibroblasts were further expanded in DMEM containing 
10% FBS and 1% PSF and stored frozen in liquid nitrogen at passage 4. All experiments were 
performed using fibroblasts between subsequent passages 4 and 10. 
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Minimum Inhibitory and Minimum Bactericidal Concentrations (MIC and MBC) 
MIC and MBC values of the P. gingivalis strains W83, HG91 and ΔEpsC mutant were 
determined by a standard broth dilution method [23]. The MIC and MBC values were 
determined both in BHI and in DMEM enriched with 10% FBS. Briefly, P. gingivalis strains 
were grown anaerobically in BHI containing hemin and menadione for 18 hours at 37˚C, the 
OD690 was determined and based on the standard growth curves, the numbers of bacteria were 
calculated. Metronidazole (Sigma-Aldrich, the Netherlands) and amoxicillin (Beecham research 
laboratories, Beecham Pharma, Amstelveen, the Netherlands) solutions were prepared in sterile 
distilled water and filter sterilized with sterile polypropylene syringe filters (Whatman® FP 
30/0.2, 0.2 μm pore size, GE Healthcare Europe GmbH, Belgium). Metronidazole and 
amoxicillin were serially diluted in a 24-wells-plate in BHI enriched with hemin and menadione 
and an inoculum containing 1×108 P. gingivalis was added to each well. P. gingivalis strains 
without antibiotics and antibiotics without P. gingivalis served as controls. Four different 
concentrations of metronidazole; 2 μg/ml, 1 μg/ml, 0.5 μg/ml and 0.25 μg/ml and amoxicillin; 
0.5 μg/ml, 0.25 μg/ml, 0.125 μg/ml and 0.062 μg/ml were used for MIC and MBC 
determination. Each concentration of metronidazole (2 μg/ml, 1 μg/ml, 0.5 μg/ml and 0.25) was 
combined with respective concentration of amoxicillin (0.5 μg/ml, 0.25 μg/ml, 0.125 μg/ml and 
0.062 μg/ml) for the in vitro combination antibiotic treatment. 
Invasion efficiency 
An antibiotic protection assay for P. gingivalis [12] was used to quantify the invasion efficiency 
of the three P. gingivalis strains. GFs were seeded into 24-wells-plates at a cell density of 1× 104 
cells/well, in antibiotic free DMEM containing 10% FBS and grown until sub-confluence. P. 
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gingivalis grown overnight in BHI broth with hemin and menadione, and harvested at the log 
phase (OD690 of 0.8) by centrifugation. These P. gingivalis were washed first with PBS (pH 7.4) 
and then with DMEM without antibiotics before suspending them in DMEM containing 10% 
FBS without antibiotics. The OD690 was again measured in DMEM to establish the CFUs. The 
numbers of P. gingivalis were adjusted to be used subsequently for infecting the fibroblasts with 
a multiplicity of infection (MOI) 100 (1×106/well) and 1000 (1×107/well) P. gingivalis per GF. 
Only DMEM containing 10% FBS was added to the control GFs. P. gingivalis without GFs in 
concentration of 1×108/ml were also included for each experiment as controls to evaluate 
efficiency of the antibiotic used for killing P. gingivalis. The bacterial suspensions in DMEM 
were added to the sub-confluent monolayers of GFs and co-incubated in humidified aerobic 
atmosphere for 90 minutes, in 5% CO2 at 37˚C. After co-incubation, the unattached bacteria 
were removed by washing each well twice with PBS. Metronidazole (100 μg/ml) was added to 
the monolayers and incubated in DMEM for another 60 minutes to kill the external adherent 
bacteria. This concentration of metronidazole was shown in pilot experiments to kill 108 P. 
gingivalis/ml during 60 minutes exposure in BHI as well as DMEM and also reported elsewhere 
[5, 12]. Monolayers were washed twice with PBS and 1 ml of sterile distilled water was added to 
each well and further incubated for 30 minutes to lyse the fibroblasts. The cells were disrupted 
by vigorous and repeated pipetting. The lysate were plated in serial dilutions for CFUs count on 
horse blood agar plates (Oxoid no.2, Basingstoke, UK) containing hemin and menadione and 
incubated anaerobically at 37˚C. The remaining samples were stored at -80˚C. CFU counts were 
determined after 14 days of anaerobic incubation. Invasion efficiency was expressed as a 
percentage of the initial inoculum recovered after GF lysis [24].  
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Survival of internalized P. gingivalis  
To study the survival of internalized P. gingivalis, the most invasive among the three P. 
gingivalis strains i.e. ΔEpsC mutant was chosen for further experiments. The highest invasion 
efficiency was seen with MOI 100, therefore only MOI 100 was used in further experiments. 
This assay was performed in two steps. The first step was performed similar to the 
antibiotic protection assay except that the GFs were not lysed at the end of the experiment. In the 
second step GFs were washed twice with PBS and either metronidazole (100 μg/ml) alone, 
amoxicillin alone (12.5 μg/ml) or combination of metronidazole (100 μg/ml) and amoxicillin 
(12.5 μg/ml) were added to the wells containing GFs and incubated for 60 minutes under 
humidified aerobic conditions at 37˚C. Concentrations of antibiotics used in this step were equal 
to 100 times the MIC. Antibiotics free DMEM was added to the control GFs. After incubation 
the GFs were washed twice with sterile PBS and lysed as described previously.  
P. gingivalis quantitation by real time Polymerase Chain Reaction (RT-PCR) 
P. gingivalis DNA was isolated from the lysate by MagNA Pure DNA Isolation kit III (Roche, 
Molecular Diagnostics, Almere, the Netherlands) as mentioned elsewhere [25]. The primer/probe 
sets and PCR conditions have been described earlier [26]. Briefly, RT-PCR amplification was 
performed in a total reaction mixture volume of 20 μL. The reaction mixtures contained 10 μL of 
LightCycler® 480 SYBR Green I Master mix, 1.8 picomole of P. gingivalis specific forward and 
reverse primers each, 0.4 picomole of LightCycler® 480 CYAN 500 Labeling Reagent and 4 μL 
of purified P. gingivalis DNA from the samples. The samples were subjected to an initial 
amplification cycle of 50°C for 2 minutes and 95°C for 10 minutes followed by 45 cycles at 
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95°C  for 15 seconds and 60°Cfor 1 minute using the LightCycler® 480 Instrument. Data 
analysis was done with LightCycler®  480 software release 1.5.0 SP4.  
Statistical analysis                                                                                                              
 Mean and standard error of the mean (SEM) were calculated from three separate experiments 
for antibiotic protection assays. Data from the culture and RT-PCR were compared and tested for 
significance either using a two tailed, non-parametric Mann-Whitney’s test or a non-parametric 
Kruskal-Wallis and Dunn’s multiple comparison post hoc tests. Data analysis was performed 
with GraphPad Prism software (version 5.00 for Windows, San Diego California, USA). 
Differences were considered statistically significant at a p value < 0.05. 
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Results 
 MIC and MBC  
Table 1 presents the MIC and MBC values for different P. gingivalis strains as determined by 
broth dilution method. The MIC and MBC values of amoxicillin alone for the three P. gingivalis 
strains ranged between 0.125 μg/ml and 0.25 μg/ml. MIC and MBC values of metronidazole 
alone for the three P. gingivalis strains ranged between 1 μg/ml and 2 μg/ml. MIC and MBC 
values for the combination ranged between 1 μg/ml metronidazole plus 0.125 μg/ml amoxicillin 
and 2 μg/ml metronidazole plus 0.25 μg/ml amoxicillin.  There were no significant differences in 
susceptibility to metronidazole and amoxicillin between the encapsulated and non-encapsulated 
P. gingivalis strains W83, HG91 and ΔEpsC mutant.  
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Table 1. MIC and MBC of antibiotics as determined by broth dilution method 
 
 
 
 
 
 
 
 
MIC; minimum inhibitory concentration, MBC; minimum bactericidal concentration 
Invasion of GF by P. gingivalis 
P. gingivalis strains used in this study were able to invade and survive inside GF. Figure 1 shows 
the invasion efficiencies of the three P. gingivalis strains at MOI 100 and 1000, after 90 minutes 
of infection, as determined by anaerobic culture. Invasion efficiencies of W83 wild type, HG91 
and ΔEpsC mutant at MOI 100 were 0,007%, 0.07% and 0.15% respectively. At MOI 1000, 
respective invasion efficiencies of W83 wild type, HG91 and ΔEpsC mutant were 0.016%, 
0.04%, 0.09%. Invasion efficiencies of the non-encapsulated strains between MOI 100 and MOI 
1000 were not statistically different. 
 
P. gingivalis strain (serotype) 
MIC/MBC (μg/ml) 
Metronidazole  Amoxicillin  Metronidazole + Amoxicillin 
W83 ( K1) 1.0/2.0 0.25/0.25 1+0.125/ 2+0.25 
HG91(K-) 2.0/2.0 0.25/ 0.25 1+0.125/1+0.125 
ΔEpsC (K-) 1.0/2.0  0.125/0.25  1+0.125/1+0.25  
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The non-encapsulated P. gingivalis ΔEpsC mutant was significantly more invasive than 
the encapsulated W83 parent strain at MOI 100 (p-value = 0.025) as well as MOI 1000 (p-value 
= 0.038) (Figure 1). Invasion efficiency of the non-encapsulated HG91 strain was also higher 
than the encapsulated W83 strain at MOI 100 and 1000, although the differences did not reach 
statistical significance.  
Overall, the RT-PCR data show comparable results as seen for anaerobic culture (Figure 
2). There were no statistically significant differences in the amounts of P. gingivalis detected by 
RT-PCR either between W83 and HG91 or HG91 and ΔEpsC mutant at MOI of 100 (Figure 2). 
However at MOI 1000, the detected amounts of ΔEpsC were significantly higher than the wild 
type W83 (p value = 0.027).  
In vitro survival of internalized P. gingivalis  
The internalized ΔEpsC mutant was further treated with different regimens of antibiotics. After 
the additional in vitro antibiotic treatment of internalized ΔEpsC mutant, viable P. gingivalis 
could still be recovered from the GFs regardless of the antibiotics used. When compared to the 
total amounts of internalized bacteria (i.e. bacteria left after the first antibiotic treatment), the 
mean percentages ranged from 13.5% to 17.8% depending on the antibiotic(s) used (Figure 3), 
differences were not significant. Survival of the internalized ΔEpsC mutant was significantly (p-
value = 0.034) reduced compared to control, if a combination of metronidazole and amoxicillin 
was used (Figure 4). Either metronidazole alone or amoxicillin alone was not able to 
significantly reduce the internalized load of P. gingivalis (Figure 4). 
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Figure 1 
 
Invasion efficiencies of P. gingivalis strains into GF at MOI 100 and 1000, as determined by anaerobic 
culture. The non-encapsulated mutant of W83 (ΔEpsC) was significantly more efficient in invading GF 
compared to the encapsulated wild type (W83) both at MOI 100 (* p-value = 0.025) and MOI 1000 (** p-
value = 0.038). Results are presented as the mean and SEM of triplicate cultures and represent three 
independent experiments.  
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Figure 2 
Invasion efficiencies of P. gingivalis at MOI 100 and 1000 as determined by RT-PCR. The  
invasion efficiency of ΔEpsC mutant into GFs was significantly higher than the wild type  
W83 at MOI 1000 (*p-value = 0.027). Results are presented as the mean and SEM of triplicate cultures 
and represent three independent experiments. 
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Figure 3  
 
ΔEpsC P. gingivalis recovered by anaerobic culture after in vitro challenge of the internalized 
bacteria with metronidazole (100 μg/ml), amoxicillin (12.5 μg/ml) or combination o 
metronidazole (100μg/ml) and amoxicillin (12.5 μg/ml), shown here as mean percentages of the 
initially internalized bacteria at MOI 100. No viable P. gingivalis were recovered from the 
control. 
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Figure 4 
 
Survival of P. gingivalis (ΔEpsC mutant) recovered by anaerobic culture after in vitro challenge 
of the internalized bacteria with metronidazole (100 μg/ml), amoxicillin (12.5 μg/ml) or 
combination of  metronidazole (100 μg/ml) and amoxicillin (12.5 μg/ml). A significant reduction 
in the survival of internalized bacteria was observed after combination of metronidazole and 
amoxicillin treatment, compared to control (*p-value = 0.034). Results are presented as the mean 
and SEM of triplicate cultures and represent three independent experiments. 
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Discussion 
Clinical studies on periodontitis and peri-implantitis patients treated with antibiotics have 
reported inability of antibiotics to completely eradicate P. gingivalis [27, 28]. This observation is 
in line with the finding that periodontal pathogens internalized into host cells might act as a 
potential reservoir for re-infection in periodontitis [29]. The re-emergence of P. gingivalis has 
particularly been attributed to failed eradication [30]. Invasion of host cells is one of the possible 
mechanisms that can offer protection to bacteria against antibiotic pressure [31]. GF appear to be 
important host cells in this regard because periodontal pathogens have been previously shown to 
invade into and survive inside GFs [13, 32]. Intracellular P. gingivalis undergoes morphologic 
changes and has been shown by scanning electron microscopy in the cytoplasm without 
membrane surrounding [13].  
In the current study both encapsulated and non-encapsulated P. gingivalis strains were 
able to invade into GFs; however differences were found in their invasion efficiencies. The non-
encapsulated ΔEpsC mutant was significantly more invasive than its encapsulated wild type 
strain W83. Invasion efficiency of the naturally non-encapsulated HG91 strain also tended to be 
higher than the encapsulated W83 but the difference did not reach statistical significance. This 
indicates that the capsule of W83 is mainly responsible for the differences in the invasion 
efficiencies between the parent W83 strain and its non-encapsulated isogenic ΔEpsC mutant. 
Factors other than the capsule may confound a comparison between a non-encapsulated P. 
gingivalis strain e.g. HG91, with an encapsulated one e.g. W83. Furthermore, in the current 
study we found the highest invasion efficiency with MOI 100, which is consistent with previous 
studies [13, 24].  There may be a threshold for a fibroblast to optimally internalize a certain 
number of P. gingivalis and increasing the number of bacteria beyond the threshold may not 
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further enhance invasion. The non-encapsulated ΔEpsC mutant, being the most invasive of the 
three P. gingivalis strains used, was chosen for further experiments to study the survival of 
internalized P. gingivalis to in vitro antibiotics treatment. The results show that P. gingivalis can 
resist antibiotic treatment inside fibroblasts. Persistence and/or multiplication of P. gingivalis 
after internalization and survival in GF, was not evaluated in the current study although other 
studies have shown that P. gingivalis can persist and multiply inside host cells after 
internalization [14]. In the current study, combination of metronidazole and amoxicillin was 
found to be significantly more effective in reducing the amounts of internalized P. gingivalis 
compared to control. Clinical isolates of P. gingivalis may be more difficult to eradicate 
compared to laboratory strains, with the antibiotic therapy for periodontitis and peri-implantitis 
because clinical isolates of P. gingivalis have been found to be considerably more resistant to 
antibiotic treatment inside host cells [33]. Since growth of fibroblasts can be affected by 
anaerobic conditions [34], antibiotic protection assays in the current study were carried out under 
aerobic conditions according to the standard protocol used in previous studies [35]. 
Metronidazole is used to treat periodontal and peri-implant infections either alone or in 
combination with amoxicillin [15]. Once taken up by the bacterial cell, metronidazole reacts with 
bacterial DNA, resulting in bacterial cell death [36]. Although we have not tested entry of 
metronidazole into gingival fibroblasts in the current study, metronidazole is known to cross cell 
membrane of gingival fibroblasts [37]. It has been shown in an in vitro study that P. gingivalis 
internalized into host cells can survive metronidazole concentrations of up to 100 times its MIC 
[33]. Amoxicillin is a β-lactam antibiotic which is bactericidal and act by inhibiting bacterial cell 
wall synthesis [38]. Penicillins do not readily cross plasma membrane which limits their ability 
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to kill intracellular bacteria [39]. The inability of metronidazole and amoxicillin to effectively 
eliminate internalized P. gingivalis is in line with clinical studies [16, 17].  
Evasion of the host defence mechanisms and invasion of host tissues to maintain a 
successful infection are the prerequisites for a successful chronic infection. The capsule of P. 
gingivalis has been particularly implicated in the reduction of host immune response and 
increase in virulence [40]. Recent studies have confirmed the immunomodulatory role of P. 
gingivalis capsule in interaction with host cells [41]. Invasion of non-phagocytic host cells is yet 
another important mechanism of P. gingivalis to maintain a successful infection. The role of P. 
gingivalis capsule in its ability to invade GF has not been reported previously. Polysaccharide 
capsule of P. gingivalis may interfere with the initial step of bacterial binding to host cell 
membrane. For example, the polysaccharide capsule of P. gingivalis decreases their surface 
hydrophobicity [42], which may partly explain the higher affinity and increased invasion 
efficiency of non-encapsulated strains to host cells [10, 43]. The capsule has also been shown to 
impede host cell invasion in other  pathogens such as Klebsiella pneumoniae [44] and 
Haemophilus influenzae [45]. In case of GF, the mechanism of invasion by P. gingivalis is not 
fully understood, although P. gingivalis has been reported to exploit host cell signaling pathways 
and cytoskeleton for its internalization into gingival epithelial cells [24, 46]. Other invasive 
bacterial species have also been shown to rely on the host cell actin cytoskeleton for a successful 
infection [47]. Once inside host cell, P. gingivalis can promote its survival by activating a variety 
of apoptotic pathways [48] and regulation of distinctive P. gingivalis proteins and genes [49]. 
These observations show the strategies that P. gingivalis has evolved to increase its chances of 
survival inside the host cell although their relevance for P. gingivalis-fibroblast interactions has 
yet to be determined. The in vitro inability of high concentrations of antibiotics to kill P. 
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gingivalis internalized into GF, shown in this study; provide further support to the idea that GF 
may play an important role in P. gingivalis resistance to antibiotics. Although the evidence that 
P. gingivalis, to a certain extent, can invade host cells and resist antibiotic treatment is in line 
with clinical studies, in vitro studies may not be directly extrapolated to in vivo situation.  
Within the limitations of the study, we conclude that P. gingivalis can internalize human 
gingival fibroblasts in vitro, non-encapsulated P. gingivalis is more efficient in invading GFs 
than encapsulated P. gingivalis and once inside the host cell, P. gingivalis can survive antibiotic 
treatment. 
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Abstract 
Background and Objective: To assess inflammatory reactions of fibroblasts in the pathophysiology of 
peri-implantitis, we compared the pro-inflammatory and matrix-degrading responses of gingival and 
granulation tissue fibroblasts from periodontally healthy controls, peri-implantitis, and periodontitis 
lesions to an in vitro challenge with Porphyromonas gingivalis. Methods: Fibroblasts from periodontally 
healthy, peri-implantitis and periodontitis donors were challenged with viable P. gingivalis. The 
inflammatory responses of fibroblasts were analyzed before and after 6h P. gingivalis-challenge, and 2.5h 
and 18h after removal of the challenge. Gene-expression and induction of pro-inflammatory mediators, 
and matrix-metalloproteinases (MMPs) were assessed by real-time-PCR. Protein expression was 
measured by ELISA. Results: Non-challenged fibroblasts from peri-implantitis and periodontitis lesions 
expressed higher levels of interleukin (IL)-1β, IL-8 and monocyte chemotactic protein (MCP) -1 than 
fibroblasts from periodontally healthy individuals. The P. gingivalis-challenge induced expression of IL-
1β, IL-8, IL-6, MCP -1 and MMP-1 in periodontitis and peri-implantitis fibroblasts, but not in fibroblasts 
from periodontally healthy individuals. MMP-8 expression was higher in the non-challenged peri-
implantitis fibroblasts than in fibroblasts from periodontally healthy individuals. However, the P. 
gingivalis-challenge down-regulated MMP-8 gene expression in peri-implantitis fibroblasts. After 
removal of the P. gingivalis-challenge, peri-implantitis fibroblasts had higher induction of IL-1β, MCP-1 
and MMP-1 compared to periodontitis fibroblasts. Conclusions: Fibroblasts from peri-implantitis and 
periodontitis lesions gave a more pronounced inflammatory response to the P. gingivalis-challenge than 
fibroblasts from healthy donors. They may thereby be involved in the development of inflammation in 
peri-implantitis and periodontitis. Moreover, the sustained up-regulation of inflammatory mediators and 
MMP-1 in peri-implantitis fibroblasts may play a role in the pathogenesis of peri-implantitis.
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Introduction  
Peri-implantitis is an inflammatory disease affecting the alveolar bone and mucosal tissues 
surrounding the dental implant and is characterized by mucositis and loss of osseous integration 
[1]. Peri-implantitis shares important characteristics with chronic periodontitis, such as presence 
of chronic inflammation and bacterial species associated with the initiation and progression of 
the disease [2, 3]. Moreover, patients with a history of periodontitis may be more susceptible for 
developing peri-implantitis [4, 5]. Despite similarities, important differences exist between peri-
implantitis and periodontitis. In contrast to the often localized horizontal bone loss around 
natural teeth in periodontitis, bone loss around  implants shows a circumferential and angular 
pattern [6]. Inflammatory lesions in experimentally induced peri-implantitis have been shown to 
be more aggressive and extensive compared to similar lesions around natural teeth [7]. 
Additionally, it has been reported that inflammation around implants does not always resolve 
with the removal of infection [8].  
Although the etiology of peri-implantitis is multifactorial, certain microorganisms are 
essential for its initiation and progression [2]. Porphyromonas gingivalis is a Gram-negative, 
anaerobic bacterium that is strongly associated with peri-implantitis [9].  It has a variety of ways 
to interact with host cells [10]. Tissue destruction in peri-implantitis in response to bacteria such 
as P. gingivalis is a result of the persistent and ineffective inflammatory immune responses from 
host cells. Host cells respond to bacterial challenge by releasing certain pro- and anti-
inflammatory mediators which in turn mediate degradation of collagen and extracellular matrix, 
and bone resorption [11]. The role of these mediators in the pathogenesis of peri-implantitis has 
been reviewed in literature [12].  
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Despite the important role of bacteria in peri-implantitis, these bacteria can also be found 
in small numbers in apparently healthy oral cavities [13], which emphasises the fact that bacteria 
are not solely responsible for causing the disease. In addition, patients who have already lost an 
implant are at greater risk for subsequent implant losses [14]. Thus, host related factors are also 
important in the development of peri-implantitis.  
Fibroblasts play an important immunomodulatory role in the disease progression and 
tissue destruction in peri-implantitis [15,16] for the following reasons: (i) fibroblasts respond to 
P. gingivalis infection by releasing inflammatory mediators such as interleukins (IL)-1β, IL-6, 
IL-8 [17] and monocyte chemotactic protein (MCP) -1 [18]. These inflammatory mediators 
increase tissue perfusion, recruit different immune cells, amplify the overall inflammatory 
process and thereby they can indirectly enhance tissue damage. [19] Fibroblasts challenged with 
P. gingivalis release matrix metalloproteinases (MMPs) [20], which, besides degrading 
extracellular matrix, can also break down some pro-inflammatory mediators into smaller 
fragments and thus may activate or deactivate these molecules [21]. (iii) Fibroblasts also produce 
tissue inhibitor of metalloproteinases (TIMPs), which tend to restrict matrix breakdown by 
MMPs [15, 22] and (iv) transforming growth factor-beta (TGFβ)-1 which regulates fibrogenesis 
as well as vascular homeostasis [23].  
 Even though specialized immune cells such as monocytes/macrophages, lymphocytes 
and neutrophils play important role in inflammation, these cells only transiently produce 
inflammatory mediators and they can develop tolerance to certain virulence factors of oral 
bacteria [24]. Fibroblasts on the other hand do not develop such tolerance and may play an 
important role in sustaining inflammation [25]. This is particularly relevant for peri-implantitis 
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lesions because in contrast to the effectiveness of non-surgical treatment for periodontitis [26], 
peri-implantitis lesions may not respond very well to non-surgical treatment [27].  
Because of relative abundance in the peri-implant granulation tissue, it is important to 
study the role of fibroblasts in the inflammatory process and their responses to microbial 
challenge in peri-implantitis. It is not known how peri-implant granulation tissue fibroblasts 
(PIGFs) interact with bacteria associated with peri-implantitis such as P. gingivalis. Since 
fibroblasts from different anatomical sites or the same anatomical site but different diseases play 
distinct roles [28, 29], we hypothesized that fibroblasts from peri-implantitis lesions respond 
differently to P. gingivalis challenge compared to fibroblasts from periodontitis lesions and may 
play a role in the pathogenesis of peri-implantitis. Therefore, the aim of this study was to 
compare the pro-inflammatory and matrix-degrading responses of fibroblasts from periodontally 
healthy controls, peri-implantitis, and periodontitis lesions to an in vitro Porphyromonas 
gingivalis-challenge. 
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Material and methods 
Tissue donors and fibroblast isolation 
Peri-implant granulation tissue fibroblasts (PIGFs) were obtained from 7 peri-implantitis patients 
during flap surgery as part of peri-implantitis treatment. The surgical approach consisted of an 
incision extending mesially and distally to the implant after the removal of prosthetic 
suprastructure to facilitate access. A full thickness tissue flap was reflected and the inflamed 
granulation tissue was carefully removed with a curette. The tissue samples were further 
processed on the same day. The peri-implantitis patients were free from active periodontitis and 
had no known history of periodontitis. Gingival fibroblasts from 5 periodontally healthy controls 
(HGF) and 9 chronic periodontitis patients (PGF) were recovered by collecting gingiva-remains 
from  extracted  teeth using a scalpel as described before [18]. Periodontally healthy controls 
underwent tooth-extraction as part of treatment for other reasons than periodontitis and showed 
no signs of inflammation/periodontitis/loss of alveolar bone. From periodontitis patients, teeth 
displaying deepened pockets, bleeding on probing, and advanced loss of alveolar bone visible on 
radiographs were extracted as part of periodontitis treatment. None of the donors suffered from 
systemic diseases or were pregnant. None of the donors was a current smoker. All donors had 
given written informed consent, and the study was approved by the Medical Ethical committee 
of the VU University Medical Center.  
Tissue samples were washed twice in Dulbecco’s modified Eagle medium (DMEM; 4.5 
g/L glucose + L-glutamine + pyruvate; Invitrogen/Gibco Paisley, UK) supplemented with 10% 
fetal bovine serum (FBS; HyClone, Logan, UT, USA) and 2% antibiotics/antimycotics (PSF; 
100 U/ml of penicillin, 100 μg/ml streptomycin and 250 ng/ml of amphotericin B; Sigma, St 
Louis, MO, USA) and cultured in DMEM containing 10% FBS and 2% PSF, in a humidified 
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atmosphere with 5% CO2 at 37˚C until growth of fibroblasts was seen under the phase contrast 
microscope (Olympus CK2, Olympus, Japan). Cells were expanded in larger cell culture flasks 
and stored in liquid nitrogen at passage 4. Morphologically HGF, PIGF and PGF had similar 
appearance under the phase contrast microscope. Furthermore, the fibroblastic nature of HGF, 
PGF and PIGF was assessed by evaluating the expression of FMOD (fibromodulin) gene, a 
marker for HGF [30], which was expressed at similar levels in HGF, PGF and PIGF (data not 
shown). Experiments were performed with cells from passages 5-7. 
Bacterial strain and culture  
P. gingivalis HG91 (also designated as strain 381) was cultured anaerobically (80% N2, 10%H2, 
10% CO2) until log-growth phase in Brain-Heart Infusion (BHI)-broth supplemented with hemin 
(5mg/l) and menadione (1mg/l). Purity was checked with Gram-staining.   
Viable P. gingivalis were harvested by centrifugation. Bacterial pellets were washed 
twice in sterile phosphate buffered salt solution (PBS, Gibco BRL, Paisley, Scotland) and re-
suspended in antibiotic/antimycotic-free DMEM with 10% FBS. The optical density was 
measured at 690 nm to establish the number of colony forming units (CFUs). A suspension of 2 
x108 CFU/ml was used to challenge the fibroblasts.  
P. gingivalis challenge to fibroblasts  
Fibroblasts were challenged with viable P. gingivalis as reported previously [138]. In short, 
fibroblasts (104/well) were grown until sub-confluence in 24-well plates. Medium was removed 
and replaced with 0.5 ml of a P. gingivalis HG91 suspension of 2 x108 CFU/ml in antibiotic-free 
DMEM with 10% FBS. Only DMEM without PSF, supplemented with 10% FBS was added to 
control fibroblasts (non-challenged).  
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 HGFs, PGFs and PIGFs were incubated with P. gingivalis for 6h. After the P. gingivalis 
challenge, fibroblast morphology was checked for abnormalities or cell-detachment by phase-
contrast microscopy. Subsequently fibroblasts were washed with sterile PBS and lysed in lysis-
buffer as supplied with RNeasy Mini Kit for RNA extraction (Buffer RLT, Qiagen, Hilden, 
Germany), supplemented with β-mercapto-ethanol. Experiments were performed in 
quadruplicate.  
Priming of fibroblasts by P. gingivalis and subsequent removal of the challenge 
PIGFs from 7 peri-implantitis donors and PGFs from 7 periodontitis donors were used. 
Fibroblasts (104/well) were grown until sub-confluence in 24-well plates. Medium was removed 
and replaced with 0.5 ml of a P. gingivalis suspension in antibiotic-free DMEM with 10% FBS 
and incubated for 6h as described above. At the end of the 6h challenge, P. gingivalis was 
removed by washing three times with sterile PBS. Cells were then incubated in DMEM 
supplemented with 10% FBS and 2% PSF for 30 minutes to kill the remaining P. gingivalis. 
Susceptibility of P. gingivalis to penicillin in vitro is known in the literature [31] and in our 
preliminary in vitro experiments (data not shown) this protocol proved to completely kill 
2 × 108 CFU/ml of P. gingivalis HG91. After 30 minutes, cells were washed three times with 
sterile PBS and the medium was replaced with DMEM without antibiotics. Supernatants and cell 
lysates were collected at 6h after the P. gingivalis challenge (baseline), and 2.5 and 18h after 
removing P. gingivalis. At each time point the cells were washed three times with sterile PBS 
before lysing them. The non-challenged fibroblasts underwent the same treatments and acted as 
controls for different time points. All experiments were performed in quadruplicate. 
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mRNA expression   
Fibroblast RNA was isolated using the Qiagen RNeasy Mini Kit according to manufacturers’ 
protocol. The RNA concentration was measured using a Nanodrop spectrophotometer 
(NanoDrop Technologies; Thermo-Fischer Scientific, Wilmington, Delaware, USA). mRNA was 
reverse-transcribed to cDNA using the MBI Fermentas RevertAid™ First Strand cDNA 
Synthesis Kit (Fermentas, Vilnius, Lithuania), using both the Oligo(dT)18 and the D(N)6 
primers according to manufacturers’ protocol. 
Real time PCR primers for IL-1β, IL-6, IL-8, MCP-1, TIMP-1, MMP-1, MMP-2 and 
MMP-8 were used as published previously [18, 32]. Primers for TGFβ-1 were designed using 
PRIMER EXPRESS software, version 2.0 (Applied Biosystems, Foster City, CA, USA). All primers 
were ordered from SIGMA-ALDRICH (Sigma-Aldrich Co. LLC). Sequences of the relevant 
forward and reverse primers for the respective genes are given in Table 1. We used a serial 
dilution of human reference total RNA (Stratagene, La Jolla, CA, USA) to create a standard 
curve to check the PCR-efficiency. Real-time PCR was performed on Roche LightCycler 480 (F. 
Hoffmann-La Roche AG, Basel, Switzerland). Reactions were performed with 2 ng of cDNA in 
a total volume of 11 μl containing the LightCycler® 480 SYBR Green I Master Mix (F. 
Hoffmann-La Roche AG, Basel, Switzerland), consisting of DNA double-strand-specific SYBR 
Green I dye for product detection and characterization, FastStart Taq DNA Polymerase and 
0.91 pM/μl of each primer. After an activation step with the FastStart Taq DNA Polymerase for 
5 min at 95°C, 40 cycles were run of a two-step PCR consisting of a denaturation step at 95°C 
for 10 s, annealing and extension steps of 60°C for 5 s, 72°C for 10 s and 78°C for 5 s. 
Subsequently, the PCR products were subjected to melting curve analysis to test if any 
nonspecific PCR products were generated. Samples were normalized for the expression of the 
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housekeeping gene β2-microglobulin, which was not affected by the experimental conditions. 
Relative gene expression was calculated by the method proposed by Livak et al. [33], by 
calculating the ΔCt (Ct gene of interest − Ct housekeeping gene ), and the expression of different genes was 
expressed as 2−(ΔCt). Fold increase in gene expression (induction) was expressed as 2−(ΔΔCt), 
wherein ΔΔCt = ΔCt challenged − average ΔCt-value non-challenged. 
Table 1. Real-time PCR primer sequences. 
 
Protein production 
Cell culture supernatants from 5 peri-implantitis and 5 periodontitis patients challenged with P. 
gingivalis for 6h were used for determining the protein production of IL-8, MMP-8 and TIMP-1. 
The protein levels of IL-8 were determined by Enzyme-linked immunosorbant assays (ELISA) 
(PeliKine ELISA kits, Sanquin Blood Supply Foundation, Amsterdam, the Netherlands), 
according to the manufacturers’ protocol. The sample quantities were normalized against a serial 
dilution of a known concentration of the relevant protein provided by the manufacturers. 
Sensitivity of the IL-8 assay was 1-3 pg/ml. MMP-8 and TIMP-1 concentrations in 10 × diluted 
Gene                                                                      Primer sequences 
 5’-3’ Fw 5’-3’ Rev 
IL-1β CTTTGAAGCTGATGGCCCTAAA AGTGGTGGTCGGAGATTCGT 
IL-6 GGCACTGGCAGAAAACAACC GGCAAGTCTCCTCATTGAATCC 
IL-8 GGCAGCCTTCCTGATTTCTG CTGACATCTAAGTTCTTTAGCACTCCTT 
MCP-1 CAGCCAGATGCAATCAATGC TGCTGCTGGTGATTCTTCTATAGCT 
TGFβ-1 CTCGGAGCTCTGATGTGTTGAA CACCCGCGTGCTAATGGT 
TIMP-1 CCTTCTGCAATTCCGACCTCGTC  CGGGCAGGATTCAGGCTATCTGG 
MMP-1 GAAGTTGATGAAGCAGCCCAGATGT CAGTTGTGGCCAGAAAACAGAAGTGAA
A 
MMP-2 ATCCGTGGTGAGATCTTCTTCTT AGCCAGGATCCATTTTCTTCTT 
MMP-8 GCTGCTTATGAAGATTTTGACAGAG ACAGCCACATTTGATTTTGCTTCAG 
β2-
microglobulin 
AAGATTCAGGTTTACTCACGTC TGATGCTGCTTACATGTCTCG 
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culture supernatants were measured by ELISA (Biotrak MMP-8 human ELISA system, 
Amersham Pharmacia Biotech, Buckinghamshire, UK; Quantikine human TIMP-1 
immunoassay, R&D Systems, Minneapolis, MN, USA) according to the manufacturers’ 
protocol. The average lower limits of detection were 0.032 ng/ml and 0.08 ng/ml respectively. 
All ELISA experiments were performed in duplicate.  
Statistical analysis  
Comparisons between the total mRNA expression, induction of gene expression and protein 
production between groups were tested with Student’s t test when data were normally 
distributed. Wilcoxon matched pairs and Mann-Whitney tests were used to analyze the non-
parametric data. If variances in groups were not equal, Welch’s correction for unequal variances 
was applied. Differences were regarded statistically significant at a value of p<0.05. Tests were 
performed with GraphPad Prism software (version 5, by MacKiev Software ™). 
  
 P. gingivalis-fibroblast interaction in peri-implantitis   
 
68 
 
Results 
General and clinical characteristics of the donors included in this study are shown in Table 2. No 
significant differences were found between the ages of different groups of donors. Bleeding on 
probing (BOP) was more frequently detected around target implants in peri-implantitis patients 
compared to periodontally healthy controls (p = 0.008). Compared to target teeth in periodontally 
healthy controls, higher values for probing depths were found around target implants (p = 0.005) 
in peri-implantitis and teeth (p = 0.01) in periodontitis patients.  
Table 2. Patient characteristics and clinical parameters of fibroblast donors and target 
teeth/implants. 
BOP: number of target teeth/implants showing bleeding on probing. Mean PD: mean probing depth of 
pocket in millimeters around target teeth/implants; #: fibroblasts from 5 or 7 periodontitis patients were 
used in different experiment; * p = 0.008, ** p = 0.005, *** p = 0.01 (significant difference compared to 
periodontally healthy controls) 
mRNA expression of IL-1β, IL-6, IL-8 and MCP-1 before and after the P. gingivalis 
challenge 
mRNA expression of IL-1β, IL-6, IL-8 and MCP-1 was significantly up-regulated in response to 
the P. gingivalis challenge in PIGFs (p = 0.031, 0.015, 0.0078, 0.023 respectively) and PGFs (p 
= 0.016, 0.015, 0.015, 0.03 respectively), but not in HGFs (Figure 1A-D). mRNA expression 
levels of IL-1β, IL-8 and MCP-1 in PIGFs were higher compared to HGFs both in the non-
challenged (p = 0.030, 0.045, 0.0016 respectively) as well as challenged cells (p = 0.0025, 0.045, 
0.029 respectively) (Figure 1A, C, D). mRNA expression levels of IL1-β, IL-6, IL-8 and MCP-1 
 Periodontally healthy controls Peri-implantitis Periodontitis 
N donors 5 7 9# 
Gender (Male/Female) 1/4 6/ 1 3/ 6 
Mean age  (+SD) in years 54.4 (+18.7) 57.8 (+12.4) 54.4(+9.2) 
 BOP (N) 1  7 *  5  
Mean PD (+SD) 2.7 (+0.8)  5.1 (+0.9) ** 6.6 (+2.8) *** 
Chapter 3   
69 
 
were higher (p = 0.048, 0.0025, 0.002, 0.002 respectively) in PGFs than HGFs in the non-
challenged but not in the challenged cells (Figure 1A-D). Differences in mRNA expression of 
IL-1β, IL-6, IL-8 and MCP-1 between PIGFs and PGFs did not reach statistical significance in 
the non-challenged as well as challenged cells.   
Differential expression of MMPs in response to the P. gingivalis challenge   
Compared to the non-challenged cells, the P. gingivalis challenge up-regulated expression of 
MMP-1 in PIGFs (p = 0.039) and PGFs (p = 0.047), but not in HGFs (Figure 2A). In the non-
challenged cells, mRNA expression levels of MMP-8 in PIGFs were higher than in HGFs (p = 
0.029, Figure 2B). Interestingly, mRNA expression of MMP-8 was down-regulated in the 
challenged PIGFs (p = 0.039) compared to the non-challenged PIGFs (Figure 2B). A similar 
trend was observed in the mRNA expression of MMP-8 in PGFs, but the decrease in mRNA 
expression was not significant. mRNA expression of TIMP-1 was not significantly changed in 
response to P. gingivalis challenge in any group of fibroblasts (Figure 2C), although compared to 
HGFs the expression of TIMP-1 was higher in PIGFs in the non-challenged (p = 0.048) as well 
as the challenged cells (p = 0.0051). TIMP-1 mRNA expression was also significantly higher in 
PGFs challenged with P. gingivalis compared to the challenged HGFs (p = 0.0025, Figure 2C).  
No significant differences were observed in mRNA expression levels of TGFβ-1 and 
MMP-2 either between the non-challenged versus the challenged fibroblasts of the same group or 
among different groups of fibroblasts (data not shown).  
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Figure 1  
mRNA expression levels of pro-inflammatory mediators before and after a 6h P. gingivalis 
challenge.  
mRNA expression levels of IL-1β (A), IL-6 (B), IL-8(C) and MCP-1 (D) relative to housekeeping gene 
(β2- microglobulin) in fibroblasts from periodontally healthy  individuals (HGF, N=5), peri-implantitis 
patients (PIGF, N=7) and periodontitis patients (PGF, N=7) before and after a 6h challenge with viable P. 
gingivalis (Pg). Bars represent the average + SEM of mRNA expression levels from the non-challenged 
and challenged fibroblasts from experiments performed in quadruplicate. *p < 0.05, **p < 0.01 represent 
significant difference between the non-challenged and challenged cells of the same group. † p < 0.05, ‡ 
p < 0.01 represent significant difference between different groups.  
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Figure 2  
mRNA expression levels of MMP-1, MMP-8 and TIMP-1 before and after a 6h P. gingivalis 
challenge. 
mRNA expression levels of MMP-1 (A),  MMP-8 (B) and TIMP-1 (C) relative to housekeeping gene (β2- 
microglobulin) in fibroblasts from periodontally healthy  individuals (HGF, N=5), peri-implantitis 
patients (PIGF, N=7) and periodontitis patients (PGF, N=7) before and after a 6h challenge with viable P. 
gingivalis (Pg). Bars represent the average + SEM of mRNA expression levels from the non-challenged 
and challenged fibroblasts from experiments performed in quadruplicate. *p < 0.05, **p < 0.01 represent 
significant difference between the non-challenged and challenged cells of the same group. † p < 0.05, ‡ 
p < 0.01 represent significant difference between different groups.  
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Protein production levels of IL-8, MMP-8 and TIMP-1 correspond with mRNA expression 
To confirm whether the statistically significant changes observed in mRNA expression levels 
also lead to similar changes in protein production, we measured the protein production of IL-8, 
MMP-8 and TIMP-1 by ELISA. Since there were no significant differences in the mRNA 
expression of the studied genes (except for MMP-8) between challenged and non-challenged 
HGFs, protein productions were only determined for PIGFs and PGFs. Moreover, P. gingivalis 
proteases have been reported to cleave inflammatory mediators such as IL-1β and IL-6 [18, 34]; 
therefore we chose to measure protein production levels of IL-8, MMP-8 and TIMP-1. 
Consistent with the increased mRNA expression, IL-8 protein production was also significantly 
increased in PIGFs (p = 0.002) and PGFs (p = 0.031) challenged with P. gingivalis, compared to 
the non-challenged cells (Figure 3A). Protein production of MMP-8 and TIMP-1 from PIGFs 
and PGFs before and after the P. gingivalis challenge showed similar trends to the mRNA 
expression although the differences were not significant (Figure 3B and C). Protein production of 
TIMP-1 by PIGFs was significantly higher (p = 0.008) compared to PGFs in the non-challenged 
cells (Figure 3C).  
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Figure 3  
Protein expression of IL-8, MMP-8 and TIMP-1 at before and after a 6h P. gingivalis challenge. 
Protein expression levels of IL-8 [pg/ml] (A), MMP-8 [ng/ml] (B) and TIMP-1 [ng/ml] (C) in cell culture 
supernatant from the non-challenged and challenged fibroblasts (ELISA) from peri-implantitis patients 
(PIGF, N=5) and periodontitis patients (PGF, N=5) before and after a 6h challenge with viable P. 
gingivalis (Pg). Bars represent the average + SEM of protein expression levels from the non-challenged 
and challenged fibroblasts from experiments performed in quadruplicate. *p < 0.05, **p < 0.01 represent 
significant difference between the non-challenged and challenged cells of the same group. † p < 0.05, ‡ 
p < 0.01 represent significant difference between different groups.     
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Gene induction of IL-1β, MCP-1 and MMP-1 differ between PIGFs and PGFs after 
removal of the P. gingivalis challenge 
Since there was no significant up-regulation of pro-inflammatory mediators by HGFs in response 
to P. gingivalis, only PIGFs and PGFs were used in further experiments. To assess differences in 
the dynamics of pro-inflammatory and matrix degrading responses between PIGFs and PGFs, we 
removed the P. gingivalis from fibroblast cultures after the 6h challenge and measured mRNA 
expression at 2.5h and 18h after the removal. Induction of mRNA expression for IL-1β, IL-6, IL-
8, MCP-1 and MMP-1 in PIGFs and PGFs were compared. Significantly higher gene induction 
of IL-1β, MCP-1 and MMP-1 was observed in PIGFs compared to PGFs after removal of P. 
gingivalis. No significant differences were found in the gene induction of any other mediators 
studied (data not shown). Gene induction of IL-1β was higher in PIGFs compared to PGFs 2.5h 
(p = 0. 0003) as well as 18h after the in vitro removal of P. gingivalis (p = 0.008) (Figure 4A). 
Gene induction of MCP-1 was higher in PIGFs (p = 0.01) compared to PGFs 2.5h, but not 18h 
after removal of P. gingivalis (Figure 4B). MMP-1 gene induction was also higher in PIGFs 2.5h 
(p = 0.02) and 18h (p = 0.016) after removal of P. gingivalis (Figure 4C).  
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Figure 4  
Gene induction of IL-1β, MCP-1 and MMP-1, 2.5h and 18h after removal of the P. gingivalis 
challenge. 
Gene induction (fold increase in mRNA expression in challenged compared with non-challenged cells) of 
IL-1β (A), MCP-1 (B) and MMP-1 (C) in fibroblasts from peri-implantitis patients (PIGF, N=7) and 
periodontitis patients (PGF, N=7). Bars represent the mean induction level + SEM at 2.5h and 18h after 
the removal of P. gingivalis challenge from experiments performed in quadruplicate (Due to undetectable 
levels of mRNA in the non-challenged cells of some donors, the bars for IL-1β represent data from 5 
PIGF donors at 18h; 6 and 4 PGF donors at 2.5 and 18h respectively. For MMP-1 the bars represent data 
from 5 PIGF and 5 PGF donors at 18h). *p < 0.05, **p < 0.01, p<0.001 represent significant difference 
between the groups.  
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Discussion 
In the current study, the role of fibroblasts in peri-implant inflammation and tissue breakdown in 
peri-implantitis was assessed. Studies focusing on the role of bacterial interaction with 
fibroblasts in the pathogenesis of peri-implantitis are scarce. Important differences between 
fibroblasts from peri-implantitis patients, periodontitis patients and healthy individuals have been 
reported [15, 16]. 
In the present study we found that PIGFs and PGFs were in a more pro-inflammatory 
state compared to fibroblasts from HGFs before a P. gingivalis challenge, which is consistent 
with an earlier report [16]. This implies that PIGFs and PGFs are in an activated state and 
maintain their activated state for several passages in culture. When challenged with viable P. 
gingivalis, in contrast to HGFs, PIGFs and PGFs up-regulated their IL-1β, IL-6, IL-8 and MCP-1 
gene-expression. This more pronounced response from PIGFs and PGFs to P. gingivalis may 
reflect their hyper-reactivity to bacterial challenge. MMP-1 expression was also up-regulated in 
response to P. gingivalis in PIGFs and PGFs, but not in HGFs. Interestingly, this up-regulation 
of MMP-1 was not accompanied by a significant change in expression of TIMP-1 and the 
fibrogenic factor TGFβ-1, which indicates that P. gingivalis plays a role in the matrix breakdown 
through fibroblasts. It has been reported earlier though that fibroblasts from peri-implantitis 
patients play a role in matrix breakdown by both an increased production of MMP-1 as well as 
decreased production of TIMP-1 and TGFβ-1 [15].  
We also found that non-challenged PIGFs expressed more MMP-8 compared to 
fibroblasts from HGFs, which is consistent with earlier reports that demonstrated increased 
MMP-8 levels in the peri-implant sulcular fluid of peri-implantitis patients [35]. MMP-8 is 
produced in relative large quantities by neutrophils [36] and production of MMP-8 by 
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neutrophils in peri-implant sulcus may also contribute towards the higher expression in peri-
implant sulcular fluid. In the current study, PIGFs showed a down-regulation of MMP-8 in 
response to the P. gingivalis challenge. This down-regulation of MMP-8 in response to the P. 
gingivalis challenge is interesting since a protective role for MMP-8 against site specific alveolar 
bone loss in response to P. gingivalis has been suggested [37]. This might be due to the potential 
of MMP-8 to breakdown and deactivate inflammatory mediators that are involved in periodontal 
bone resorption [38]. The down-regulation of MMP-8 in the current study may indicate that P. 
gingivalis decreases protection by MMP-8 against inflammation in peri-implantitis. However, 
fibroblasts are not the primary cells responsible for MMP-8 production. It should be noted that 
we measured total MMP-8, the expression of which could be different from active forms of 
MMP-8.  
Interestingly, we observed that after removal of P. gingivalis, the gene induction of IL-
1β, MCP-1 and MMP-1 remained significantly elevated in PIGFs. A recent study indicated that 
interaction of P. gingivalis-LPS with fibroblasts may play a role in the persistence of 
inflammation in periodontal diseases [25]. Such continuous production of inflammatory 
mediators by fibroblasts in response to P. gingivalis may play a significant role in sustaining the 
chronic inflammation and tissue damage by promoting migration of primary inflammatory 
leukocytes [39]. IL-1β is an important mediator in periodontal inflammatory diseases since it 
stimulates the production of other cytokines, chemokines, cyclooxygenase products, and MMPs 
which enhance the inflammatory process and tissue damage [40, 41]. Sustained induction of IL-
1β and MMP-1 expression by PIGFs after removal of the P. gingivalis suggests a more 
aggressive and persistent nature of inflammatory lesions around implants compared to similar 
lesions around natural teeth [7, 8]. Since we have used a non-capsular P. gingivalis strain in our 
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experiments, which can efficiently internalize into gingival fibroblasts [42], the internalized P. 
gingivalis may play a role in this persistent inflammatory response. Nevertheless, our results 
represent in vitro experiments and should be interpreted cautiously to explain the inflammatory 
response of PIGFs to in vivo infection in peri-implantitis. Moreover, in contrast to gingival or 
periodontal ligament fibroblasts, it is possible that PIGFs represent a collection of different 
fibroblast sub-populations in which case inflammatory responses from HGFs, PGFs and PIGFs 
may not be directly comparable.  
P. gingivalis plays an important role in the pathogenesis of peri-implant and periodontal 
diseases by compromising the host immune system and interacting with host cells [9, 43]. Peri-
implantitis is a multifactorial disease and besides bacteria, the inflammatory process around 
implants may also be affected by the altered anatomy resulting from the presence of a foreign 
body and absence of a physical barrier around implants in the form of periodontal ligament. 
Furthermore, the difficulty to decontaminate dental implant surface and the possible interaction 
between peri-implant tissues and implant material [44] may also play a role in the pathogenesis 
of peri-implantitis.  
In conclusion, granulation tissue fibroblasts from peri-implantitis and gingival fibroblasts 
from periodontitis lesions have a higher pro-inflammatory and matrix degrading properties and 
give a more pronounced pro-inflammatory response to an in vitro P. gingivalis-challenge when 
compared to gingival fibroblasts from periodontally healthy individuals. In addition, fibroblasts 
from peri-implantitis lesions differ from fibroblasts from periodontitis lesions by the persistent 
up-regulation of IL-1β and MMP-1 which may play a role in the more aggressive and persistent 
behavior of peri-implantitis inflammatory lesions.  
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Abstract  
Aim: Titanium-wear-particles have been found in peri-implant tissues but their role in the 
pathogenesis of peri-implantitis remains unclear. We aimed to determine the in vitro 
inflammatory responses of peri-implant-granulation-tissue fibroblasts (PIGFs) to titanium-
particles alone and in the presence of viable Porphyromonas gingivalis.  
Materials and methods: PIGFs were challenged either with TiO2-particles, P. gingivalis, or a 
combination of TiO2-particles and P. gingivalis. Gene-expression and protein-production of pro-
inflammatory mediators by PIGFs were measured with PCR and ELISA, respectively.   
Results: Higher doses of TiO2 were toxic to PIGFs and in sub-toxic doses, TiO2 caused an 
increase of gene-expression of tumor-necrosis-factor (TNF)-A and increased protein-production 
of TNF-α, interleukin (IL)-6 and IL-8. A challenge with P. gingivalis alone induced gene-
expression of TNF-A, IL-1β, IL-6 and IL-8. A combined challenge with TiO2 and P. gingivalis 
caused a stronger increase in gene-expression of TNF-A and protein-production of TNF-α and 
MCP-1 than P. gingivalis alone. 
Conclusions: TiO2-particles and P. gingivalis, individually, can induce pro-inflammatory 
responses in PIGFs. Furthermore, TiO2-particles and viable P. gingivalis further enhance gene-
expression and production of TNF-α by PIGFs. Therefore, Ti-wear-particles in the peri-implant 
tissues in combination with P. gingivalis infection, may contribute to the pathogenesis of peri-
implantitis by enhancing the inflammation in peri-implant tissues.   
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Introduction 
After the introduction of osseointegrated implants [1], the use of titanium (Ti) dental implants  
has become a successful and popular procedure in dentistry.  Despite reported high success rates 
for dental implants [2], failures can occur due to the inability of tissue to establish 
osseointegration, or due to breakdown of established osseointegration. Breakdown of established 
osseointegration may occur due to peri-implantitis and/or mechanical overload [3]. Peri-
implantitis is defined as an inflammatory lesion around the dental implant, accompanied by loss 
of supporting bone [4]. Peri-implantitis accounts for 10-50% of implant failures after at least one 
year of loading [5] and constitutes a major clinical problem. 
Multiple factors contribute to the etiology of peri-implantitis, although the general 
consensus is that peri-implantitis is infectious in nature [4]. Gram-negative anaerobic bacteria 
such as Porphyromonas gingivalis, Prevotella intermedia/Prevotella nigrescens and 
Aggregatibacter actinomycetemcomitans dominate the sub-gingival biofilm associated with peri-
implantitis [6, 7]. Porphyromonas gingivalis is strongly associated with peri-implantitis [8] and 
one of the most extensively studied oral microorganisms. It is a black-pigmented, Gram-
negative, anaerobe with a variety of virulence factors [9] such as proteases, fimbriae, LPS, and 
capsular polysaccharides, which make it a potent pathogen for the initiation and progression of 
peri-implantitis. P. gingivalis can invade and survive inside host cells [10], and it interacts with 
different host cell types to induce a network of inflammatory responses that may lead to 
breakdown of extracellular matrix and bone resorption [11, 12]. Furthermore, P. gingivalis has 
been indicated as a “keystone pathogen” [13], meaning that it can orchestrate inflammatory 
disease by altering a normally benign microbiota. 
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Due to its favorable biocompatibility [14], contemporary dental implants are almost 
exclusively made from commercially pure Ti or its alloys. Rutile oxidization of Ti implants is 
used to modify its surface [15], leading to increased wear debris production [16]. Furthermore, 
the corrosion resistance of Ti is decreased under low dissolved-oxygen conditions such as in the 
oral cavity, particularly in the presence of small amounts of fluoride [17]. Consequently, Ti 
particles have been detected in the peri-implant tissues of individuals with dental Ti implants 
[18, 19]. In a recent study [19], the size of Ti particles detected in peri-implant tissue ranged 
from 0.9+0.7μm to 3+2μm. Released Ti is capable of inducing immune responses in human cells 
[20, 21], and may play a pivotal role in bone resorption at the interface of bone and dental 
implants [22, 23]. An association between wear debris from Ti implants and peri-implantitis has 
also been suggested [24]. It was demonstrated that Ti and Escherichia coli-LPS together have a 
synergistic effect on the inflammatory responses of host cells [21]. Moreover, Ti particles have 
been detected by transmission electron microscopy inside fibroblasts and macrophages of 
patients treated with Ti-miniplates to stabilize fractured bones [25]. 
Fibroblasts play an important role in the pathogenesis of peri-implantitis and periodontal 
diseases [26]. Apart from their structural role, fibroblasts in the periodontal and peri-implant 
tissues also take part in host immune responses. Upon a P. gingivalis-challenge , fibroblasts can 
release a variety of inflammatory mediators including interleukins (IL)-1β, IL-6, IL-8, monocyte 
chemotactic protein (MCP)-1, prostaglandin E2 and matrix metalloproteinases (MMPs) [27-29].  
To the best of our knowledge, the influence of Ti on fibroblast-bacterium interaction in 
peri-implantitis has not been studied previously. To mimic in vivo conditions, it is important to 
evaluate the inflammatory responses of fibroblasts to P. gingivalis in the presence of Ti. We 
hypothesized that Ti particles elicit inflammatory responses in peri-implant granulation tissue 
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fibroblasts (PIGFs) and alter inflammatory responses of PIGFs to a P. gingivalis-challenge. 
Therefore, the purpose of this study was to determine the influence of Ti on the in vitro 
inflammatory responses of peri-implant granulation tissue fibroblasts to viable P. gingivalis.  
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Materials and methods 
Preparation of TiO2 particles  
Commercially pure rutile TiO2 microparticles (Sigma-Aldrich, Buchs, Switzerland, size <5μm, 
average=2.3μm) were treated with nitric acid and sodium hydroxide to remove adherent 
endotoxins as described earlier [30]. After deactivation with 25% nitric acid at 70°C for 1h, the 
particles were washed three times with endotoxin free phosphate buffered saline (PBS, Sigma-
Aldrich, St. Louis, MO) and incubated in 70% alcohol at room temperature for 30min. 
Subsequently, the particles were incubated in five alternating cycles of 0.1N NaOH/95% ethanol 
(20h, 30°C) and 25% nitric acid (20h, room temperature) with three times sterile PBS wash 
between each cycle. Hereafter, particles were washed and resuspended in PBS. Particle numbers 
were determined with flow cytometry (BD AccuriTMC6, BD Biosciences). The TiO2 powder 
contained on average+ SD, 17.5 (+ 3.6) particles/ng. The particles were resuspended in 
Dulbecco’s modified Eagle medium (DMEM; 4.5g/L glucose+L-glutamine+pyruvate; 
Invitrogen/Gibco Paisley, UK).  
Tissue donors and fibroblast isolation 
Peri-implant granulation tissue fibroblasts (PIGFs) from 10 peri-implantitis patients were 
obtained during open flap debridement as part of the peri-implantitis treatment. The surgical 
approach consisted of an incision extending mesially and distally to the implant after the removal 
of prosthetic suprastructure to facilitate access. A full-thickness tissue flap was reflected and the 
inflamed granulation tissue was carefully removed with a sterile curette. The tissue samples were 
processed further on the same day. All donors had given written informed consent, and the study 
was approved by the Medical Ethical committee of the VU University Medical Center.  
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 Tissue samples were processed further as described before [27].  Cells were stored in 
liquid nitrogen at passage 4. The fibroblastic nature of PIGFs was assessed by the expression of 
fibromodulin (FMOD), a marker for gingival fibroblasts [31], which was expressed at similar 
levels in gingival fibroblasts from healthy individuals and PIGF. Experiments were performed 
with cells from passages 5-8. 
Cell viability assay 
To establish the TiO2 particle concentration range not significantly reducing the viability of 
PIGFs, the proportions of surviving PIGFs were measured by the 4-[3-(4-iodophenyl)-2-(4-
nitrophenyl)-2H-5-tetrazolio]-1, 3-benzene disulfonate (WST-1) assay (Roche Diagnostics 
Nederland BV, Almere, The Netherlands) according to the manufacturers’ protocol. PIGFs from 
6 peri-implantitis patients were seeded in 24-well plates at a concentration of 105cells/well in 
DMEM containing 1% PSF and 10% FBS. After 24h, TiO2 particles suspended in DMEM at 
concentrations of 100, 50, 25 and 10 particles/PIGF were added to the wells containing PIGFs. 
PIGFs in DMEM served as positive controls while 5% Triton X-100 in DMEM was added to 
PIGFs to serve as negative controls. After incubation of the cells for 24h, WST-1 at a 
concentration of 100ul/ml of DMEM was added to each well. After incubating the cells with 
WST-1 reagent for 2h, the 24-well plates were shaken for 1min and 100 μl of cell culture 
supernatant was transferred to a 96-well plate which was analysed in a microplate reader 
(Synergy HT, Biotek Instruments). Absorbance was measured at 450nm (reference wavelength: 
650nm). Taking metabolic activity of the untreated cells as a reference (100% viability), viability 
of the test samples was expressed in percent viable cells.   
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Bacterial culture and effect of TiO2 on P. gingivalis growth 
P. gingivalis HG91 (FDC381) was cultured anaerobically (80%N2, 10%H2, 10%CO2) until log-
growth phase in Brain-Heart Infusion (BHI)-broth supplemented with hemin (5mg/l) and 
menadione (1mg/l). Purity of bacterial cultures was checked with Gram-staining.   
Viable P. gingivalis were harvested by centrifugation, pellets were washed twice in 
sterile PBS and re-suspended in antibiotic/antimycotic-free DMEM. The optical density was 
measured at 690nm to establish the number of colony forming units (CFUs). A suspension of 
2x108 P. gingivalis CFU/ml was used to challenge the PIGFs.  
To study the effect of TiO2 on P. gingivalis in different experiment conditions, pellets 
were re-suspended in; i) BHI with hemin and menadione, containing TiO2 particles (285μg/ml, 
equal to 25 TiO2 particles/PIGF) and grown anaerobically for 6h, ii) DMEM containing TiO2 
particles (285μg/ml) and grown for 6h or iii) DMEM without TiO2 and grown aerobically for 6h. 
The suspensions were plated in serial dilutions for CFU count on horse blood agar plates (Oxoid 
no.2, Basingstoke, UK) supplemented with hemin (5mg/l) and menadione (1mg/l), before and 
after TiO2 incubation. Three independent P. gingivalis HG91 cultures were used for different 
experiment conditions.  
Pre-incubation of fibroblasts with TiO2 followed by a P. gingivalis-challenge 
PIGFs (105/well) were grown in DMEM containing 1%PSF and 10%FBS in 24-well plates. At 
sub-confluence, PIGFs were washed with DMEM without antibiotics and serum, and pre-
incubated for 18h either in DMEM alone or DMEM containing 10 or 25TiO2 particles/PIGF 
(Ti10 and Ti25, respectively) in a humidified atmosphere with 5%CO2 at 37˚C. Medium was 
removed and replaced with either 0.5ml of DMEM alone (control) or 0.5ml of DMEM 
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containing P. gingivalis HG91 suspension of 2x108CFU/ml and further incubated for 6h. 
Morphology of PIGFs was checked for abnormalities or cell-detachment by phase-contrast 
microscopy (Olympus CK2, Olympus, Japan). Subsequently PIGFs were washed with sterile 
PBS and lysed in lysis-buffer as supplied with GeneJET RNA Purification Kit (Fermentas, 
Vilnius, Lithuania), supplemented with β-mercapto-ethanol. Cell culture supernatants from the 
different experimental conditions were stored at -80ºC. Experiments were performed in 
quadruplicate.  
mRNA expression   
PIGF RNA was isolated using the GeneJET RNA Purification Kit according to manufacturers’ 
protocol. The RNA concentration was measured using a Nanodrop spectrophotometer 
(NanoDrop Technologies; Thermo-Fischer Scientific, Wilmington, Delaware, USA). mRNA was 
reverse-transcribed using the MBI Fermentas RevertAid™ First Strand cDNA Synthesis Kit 
(Fermentas, Vilnius, Lithuania), using both the Oligo(dT)18 and the D(N)6 primers according to 
manufacturers’ protocol. 
Real-time PCR primers for TNF-A, IL-1β, IL-6, IL-8 and MCP-1 were designed using 
Primer Express software, version 2.0 (Applied Biosystems, Foster City, CA, USA) and used as 
published previously [27]. To avoid amplification of genomic DNA, each amplicon spanned at 
least one intron. A serial dilution of human reference total RNA (Stratagene, La Jolla, CA, USA) 
was included as an external standard to check PCR efficiency. To test if nonspecific products 
were generated, PCR-products were subjected to melting curve analysis. PCR was performed on 
Roche LightCycler 480 (F. Hoffmann-La Roche AG, Basel, Switzerland). Reactions were 
performed on Roche LightCycler 480, with 2ng of cDNA in a total volume of 11μl containing 
the LightCycler® 480 SYBR Green I Master Mix (F. Hoffmann-La Roche AG, Basel, 
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Switzerland). Gene expression was normalized for the expression of housekeeping gene β2-
microglobulin.  
Protein production 
Pelikine Enzyme-linked immunosorbant assays (ELISA) (Sanquin Blood Supply Foundation, 
Amsterdam, the Netherlands) were performed to determine protein levels of TNF-α, IL-1β, IL-6 
and IL-8 in cell-culture supernatants according to manufacturers’ protocol. Undiluted cell culture 
supernatants from PIGFs of 10 peri-implantitis patients were used. MCP-1 ELISA kits were 
purchased from Diaclone (Besancon, France) and 5x diluted samples were used to determine 
MCP-1 protein levels, according to manufacturers’ protocol. The sample quantities for all assays 
were normalized against a standard dilution of the relevant protein as provided by the 
manufacturers. ELISAs were performed in duplicate  
Statistical analysis  
Comparisons between total mRNA expression, induction of gene expression, and protein 
production were tested with paired t-test when data were normally distributed. Wilcoxon- 
matched pairs test was used to analyze non-parametric data. Differences were regarded 
significant at p<0.05. Tests were performed with GraphPad Prism software (version5, by 
GraphPad Software Inc. San Diego, CA, USA). 
Results 
Patient characteristics 
Table 1 presents clinical data of the PIGF donors. The average age (+SD) of 5 male and 5 female 
patients included in this study was 59.9 (+9.65) years. 3 out of the 10 patients were current 
smokers and 4 patients had a known history of periodontitis. The mean (+SD) pocket depth 
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around target implants was 6.1mm (+1.5mm) and soft tissues around all target implants showed 
bleeding on probing (BoP). Pus was present around target implants in 2 patients.  
Table 1. Demographic and clinical data of patients included in the study.  
PD: probing depth of pocket in millimeters around target implants; BoP: number of target Implants 
showing bleeding on probing; Pus: number of implants showing pus on examination. 
 
Effects of TiO2 on cell viability  
Figure 1 shows the viability of PIGFs after treatment with different concentrations of TiO2 
particles. The highest TiO2-concentration (100 particles/PIGF) tested in our experiment resulted 
in only 13.5% survival of PIGFs. At concentrations of 100 and 50TiO2 particles/PIGF, PIGF 
viability was reduced (p=0.0001 and 0.004, respectively) compared to non-challenged cells. 
93.8% and 77.8% of the PIGFs survived a 24h incubation with concentration of 10 and 25TiO2 
particles/PIGF, respectively. At concentrations of 10 and 25TiO2 particles/PIGF (Ti10 and Ti25, 
respectively), the viability of PIGFs was not different from non-challenged PIGFs. 
Concentrations of Ti10 and Ti25/PIGF were therefore chosen for further experiments.  
Patient characteristics (N = 10) 
Gender (male/female) 5/5 
Mean (+ SD) age in years 59.9 (+9.65) 
Current smokers (N) 3  
History of periodontitis (N) 4 
Mean (+ SD) PD 6.1 (+1.5) 
BoP 10  
Pus 2  
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Figure 1. Viability of PIGFs cultured in the presence of TiO2 
Viability of PIGFs cultured 24h in the presence of increasing concentrations of TiO2 particles (expressed 
as % of metabolic activity in comparison to the absorbance of fibroblasts incubated without TiO2) . Bars 
represent the average +SEM of viable cells from experiments performed in triplicate. * p<0.05. 
 
P. gingivalis growth in the presence of TiO2 
Growth of P. gingivalis was not affected by the presence of TiO2 in any of the tested 
experimental conditions. Before incubation with TiO2 particles, 5.9x108(+2.5 x108) CFU/ml P. 
gingivalis were recovered on blood agar plates. After treatment with TiO2 particles (285μg/ml 
equal to the concentration of TiO2 for 25 particles/PIGF) suspended in BHI under anaerobic 
conditions, on average 2.4x108(+6.0x107) CFU/ml was recovered.  
Aerobic incubation of P. gingivalis in DMEM resulted in a reduction in the number of 
viable P. gingivalis (2.2 x107+1.0x107CFU/ml). But the addition of TiO2 particles to DMEM did 
not affect the number of viable P. gingivalis (2.6x107+0.8x107CFU/ml).  
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TiO2 induces gene expression of pro-inflammatory mediators in PIGFs 
To assess inflammatory responses of PIGFs to TiO2 and P. gingivalis, mRNA expression of pro-
inflammatory mediators was determined in challenged and non-challenged cells. Incubation with 
Ti10 alone resulted in a significant (p=0.002) up-regulation of TNF-A gene expression compared 
to control PIGFs, (Figure 2A), while no significant changes were detected in the expression of 
other genes studied (Figure 2B).  
A challenge with P. gingivalis alone resulted in increased expression of TNF-A (Figure 
2A, p=0.027), IL1-β (p=0.004), IL-6 (p=0.037), IL-8 (p=0.027) and MCP-1 (Figure 2B), 
although for MCP-1, significance was not reached (p=0.06).  
When PIGFs were pre-incubated with Ti10, followed by challenge with P. gingivalis 
(Ti10-Pg), gene expression of TNF-A IL1-β, IL-8 and MCP-1 was increased (p =0.002, 0.004, 
0.002, 0.001, respectively) compared to non-challenged PIGFs (Figure 2A,B). Ti10-Pg increased 
TNF-A expression even more than P. gingivalis alone (p=0.002, Figure 2A). Compared to PIGFs 
challenged with Ti10 alone, IL-1β gene expression was higher with Ti10-Pg (p=0.008), and also 
IL-8 gene expression was increased with Ti10-Pg (p=0.08). 
Similar to Ti10, incubation with Ti25 caused up-regulation of TNF-A, and Ti25-Pg 
caused up-regulation of INF-A, IL1-β, IL-8 and MCP-1 (data not shown).  
Protein production 
Protein production of TNF-α, IL-1β, IL-6, IL-8 and MCP-1 by PIGFs was determined to 
substantiate the gene-expression data from our experiments. Very low levels of TNF-α protein 
(Figure 3) were detected in the control PIGFs and PIGFs challenged with P. gingivalis. PIGFs 
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incubated with Ti10 alone produced increased levels of TNF-α, IL-6 and IL-8 (Figure 3) 
compared to non-challenged PIGFs (p=0.002, 0.0001 and 0.002, respectively) as well as PIGFs 
challenged with P. gingivalis alone (p=0.0006, 0.0001 and 0.013, respectively).  
Pre-incubation of PIGFs with Ti10 followed by a P. gingivalis-challenge resulted in 
higher concentrations of TNF-α and MCP-1 when compared to non-challenged PIGFs (p=0.0001 
and 0.04, respectively) or, to PIGFs challenged with P. gingivalis alone (p=0.002 and 0.01, 
respectively). In contrast, lower levels of IL-6 (p=0.0001) and IL-8 (p=0.002) were detected in 
culture supernatant from PIGFs challenged with Ti10-Pg, compared to PIGFs incubated with 
Ti10 alone. IL-6 production was also lower in culture supernatant from PIGFs challenged with 
Ti10-Pg compared to non-challenged PIGFs (p=0.01).  
Concentrations of IL-1β were low in all culture supernatants, and no differences existed 
between the experimental conditions tested. 
Ti25 alone and Ti25-Pg gave protein production results comparable to Ti10 and Ti10-Pg 
results (data not shown).  
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Figure 2. Gene expression of proinflammatory mediators in PIGFs  
mRNA expression levels of (A) TNF-A, (B) IL-1β, (C)IL-6, (D) IL-8 and (E) MCP-1 in fibroblasts from 
10 peri-implantitis patients (PIGF, N=10, mean+SD). Fibroblasts were either non-challenged (Control, 
circles) or challenged with P. gingivalis alone (P. gingivalis, squares), 10 TiO2 particles/fibroblast alone 
(Ti, upward triangles) or pre-incubated with 10TiO2 particles/PIGF followed by P. gingivalis-challenge 
(Ti-P. gingivalis, downward triangles). Symbols represent the mean mRNA expression levels of each 
individual patient from experiments performed in quadruplicate. *p<0.05 represents differences between 
control and challenged cells, † p<0.05 represents differences between cells challenged with different 
conditions, ≠ indicates a trend (p<0.1) 
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Figure 3. Protein production of proinflammatory mediators by PIGFs 
The levels of secreted (A) TNF-α, (B) IL-1β, (C) IL-6, (D) IL-8 and (E) MCP-1 in culture supernatant 
from non-challenged and challenged fibroblasts from peri-implantitis patients (PIGF, N=10, mean+SD). 
PIGFs were either non-challenged (Control, circles) or challenged with P. gingivalis alone (P. gingivalis, 
squares), 10 TiO2 particles/PIGF alone (Ti, upward triangles) or pre-incubated with 10 TiO2 
particles/PIGF followed by P. gingivalis challenge (Ti-P. gingivalis, downward triangles). Symbols 
represent the mean protein levels of each individual patient from experiments performed in duplicate. * 
p<0.05 represents difference between the non-challenged and challenged cells. † p<0.05 represents 
difference between challenged cells. 
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Discussion 
In the current study, we report effects of rutile TiO2 particles on the inflammatory responses of 
peri-implant granulation tissue fibroblasts (PIGFs) to a P. gingivalis-challenge. We demonstrate 
that TiO2 particles are cytotoxic to PIGFs at high concentrations. Sub-toxic concentrations of 
TiO2 particles did not affect viability of P. gingivalis and PIGFs but did elicit inflammatory 
responses in PIGFs.  
We found that gene- and protein expression of TNF-α, IL-6 and IL-8 were increased in 
PIGFs treated with TiO2 particles alone. A challenge with P. gingivalis alone increased the 
expression of all studied genes. Furthermore, gene-expression and protein production of TNF-α 
and MCP-1 were induced even more after a combined TiO2 and P. gingivalis-challenge, 
compared to a challenge with P. gingivalis alone, indicating that the presence of TiO2 may 
enhance fibroblast responses to bacterial stimuli. IL-6 and IL-8 protein levels were strongly 
decreased in PIGFs challenged with P. gingivalis alone or a TiO2 and P. gingivalis-challenge. 
This is probably caused by activity of P. gingivalis proteases that degrade IL-6 and IL-8 [32-34]. 
Similarly, protein production of IL-1β was not affected by any experimental condition, which 
could also be because of proteolytic breakdown of IL-1β [34].  
Cytotoxic effects of Ti on host cells have been reported earlier [35], and also the ability 
of sub-toxic Ti-doses to induce inflammatory responses from various host cells has been 
demonstrated [21, 36]. Both apoptosis and necrosis have been reported as a cause of decreased 
viability after Ti exposure [37, 38] as well as apoptosis [39].The reduced cell viability we report 
here may be a combination of necrosis and apoptosis [40]. In addition, clinical studies have 
reported increased levels of, IL-1β, IL-8, IL-6 and MCP-1 in the peri-implant tissues and 
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crevicular fluid of peri-implantitis patients [41, 42]. Results of the current study show that both 
TiO2 particles and P. gingivalis, individually, can induce gene- and protein expression of pro-
inflammatory mediators in PIGFs. Moreover, when fibroblasts had been in contact with Ti 
before P. gingivalis-challenge, an augmented effect on TNF-α gene- and protein expression 
existed. By inducing the release of pro-inflammatory factors from PIGFs, the interaction of TiO2, 
P. gingivalis, and PIGFs may thereby contribute to tissue damage and bone resorption in peri-
implantitis. 
The up-regulation of TNF-α in response to TiO2 particles alone, and followed by a viable 
P. gingivalis-challenge, is interesting since TNF-α is a mediator that can trigger the release of 
various pro-inflammatory and bone-resorbing factors [43]. Nowzari et al. [44] concluded that in 
spite of minimal bacterial accumulation, TNF-α and IL-1β levels in peri-implant fluid were 
elevated compared to natural teeth. Moreover, reduction of TNF-α levels following peri-
implantitis treatment has been associated with an improvement in the clinical parameters of 
affected implants [45]. The importance of TNF-α in peri-implantitis is further evidenced by the 
fact that fibroblasts from peri-implantitis patients express multiple factors associated with peri-
implant inflammation and bone loss upon  TNF-α stimulation  [46].  
  We have previously reported that PIGFs have a distinct and peculiar role in 
inflammation associated with peri-implantitis and that unstimulated PIGFs have a higher gene-
expression of pro-inflammatory mediators compared to gingival fibroblasts from healthy 
individuals [47]. Furthermore, PIGFs retained a prolonged pro-inflammatory response to P. 
gingivalis compared to fibroblasts from periodontitis lesions. The present study suggests that 
PIGFs react to both Ti and P. gingivalis with a pro-inflammatory response and that the combined 
effect of P. gingivalis and Ti is even stronger.  
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The combined interaction of Ti and P. gingivalis with host cells has not been reported 
earlier, although it is known that LPS-coated Ti particles are able to enhance inflammatory 
responses [48, 49]. The mechanism of such responses may occur through stimulation of Toll-like 
receptors (TLRs). For instance Hirayama et al. found that expression of several TLRs in rat 
bone-marrow macrophages was affected by LPS-coated Ti particles [49]. Islam et al. showed in 
murine bone-marrow macrophages that both TLR2 and TLR4 are involved in inflammatory 
activity of Ti particles combined with bacterial substances [50]. Thus it seems likely that TLR 
activation plays a role in the combined inflammatory effects of Ti particles and P. gingivalis on 
PIGFs.  
Alternatively, Ti allergy may play a role [51]. An allergic reaction is defined as an 
excessive immune reaction that occurs after coming into contact with a known antigen [52]. 
Environmental exposure to Ti is widespread,  ranging from toothpastes to food (E171), 
cosmetics (i.e. in sunscreens) and paints [53]. Due to this widespread environmental exposure, 
the human body may contain a Ti concentration of 50 ppm [54], therefore, sensitization to Ti 
may have occurred even before the placement of a dental implant. Since the we used in our 
experiments were obtained from a sample of patients with peri-implantitis and have already been 
exposed to Ti [19], the possibility of sensitization of PIGFs to Ti cannot be ruled out.  
Although there is lack of consensus on a specific  therapy for peri-implantitis, treatment 
modalities currently in practice include non-surgical debridement of the implant surface, open 
flap debridement alone or combined with bone grafting or lasers and other surgical techniques 
[55-59]. It has been reported that implantoplasty (surgical debridement combined with 
smoothing and polishing the rough surface of titanium implants) may provide a better treatment 
option [58, 59]. However, it should be noted that implantoplasty generates Ti particles that might 
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interact with the peri-implant tissue enhance inflammation around the dental implant [60]. 
Therefore, effective measures should be taken during implantoplasty to reduce the amount of 
residual Ti in the peri-implant tissues.  
To the best of our knowledge, this study reports for the first time on the influence of TiO2 
particles on the interaction between PIGFs and viable P. gingivalis. Our results suggest that Ti 
wear debris may play an important role in inflammation associated with peri-implantitis. We 
used the non-capsular P. gingivalis strain HG91 [61]. The capsular structure of P. gingivalis may 
play a role in host-pathogen interaction since non-capsular P. gingivalis can internalize more 
efficiently into gingival fibroblasts, and induce higher pro-inflammatory responses compared to 
their capsular variants [62, 63]. P. gingivalis fimbriae might also be involved in the interaction 
between host cells and TiO2-Pg. Fimbriae are critical for invasion of host cells [64], and are also 
involved in attachment of P. gingivalis to titanium surfaces [65]. Fimbriae might thus enhance a 
close interaction between P. gingivalis, host cells and Ti particles, thereby contributing to the 
TNF-A response to TiO2-Pg. However, we sought to determine effects of viable P. gingivalis 
rather than specific virulence factors. Future in vitro and in vivo studies are needed to extrapolate 
our results to clinical situations. Likewise, other bacteria may also influence the interaction 
between host cells and Ti in peri-implantitis.  
In conclusion, rutile TiO2 particles are cytotoxic to PIGFs in high doses, and in sub-toxic 
doses they can induce pro-inflammatory responses in PIGFs. Interestingly, incubation of 
fibroblasts with TiO2 particles before a P. gingivalis-challenge enhanced gene expression and 
protein production of TNF-α even more than a challenge with P. gingivalis alone. Therefore, Ti 
wear particles in peri-implant tissues in combination with P. gingivalis infection, may contribute 
to the pathogenesis of peri-implantitis by enhancing inflammation around implants.  
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Abstract 
We aimed to evaluate the effects of non-surgical treatment with/without antibiotics (AB) on 
clinical and microbiological parameters of peri-implantitis, retrospectively.  
A total of 40 patients with ≥1 functional dental implant with bleeding on probing (BoP), pocket 
probing depth (PPD) ≥5mm, bone loss ≥3mm were selected. Data was collected from the 
patients’ database, ACTA Amsterdam at baseline and three months after treatment. From every 
patient one dental implant with the deepest PPD, BoP and bone loss was selected as a target 
implant and the deepest site as a target site. 
At target site and implant level, reduction of PPD (both p<0.001), greater mucosal recession 
[261] (p<0.001; p=0.003, respectively) and BoP (p=0.005; p<0.001, respectively) were recorded. 
In the AB group at implant level, mean MR (p=0.002) and BoP (p=0.04) improved compared 
with the no AB group. At site level mean PPD (p=0.004), MR (p=0.004) and plaque (p=0.02) 
were improved. At evaluation, 47.5% of the target implants did not need surgery. All diagnosed 
bacteria were found at baseline, except Aggregatibacter actinomycetemcomitans and at 
evaluation, Porphyromonas gingivalis was not detected in the AB group.  
In conclusion, non-surgical peri-implantitis treatment improved most of the clinical parameters, 
and AB showed additional value for MR and BoP.  
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Introduction 
Peri-implantitis is defined as chronic inflammation of the peri-implant tissues around dental 
implants with bleeding and/or suppuration on probing and crestal bone loss around a dental 
implant [1, 2]. If left untreated peri-implantitis may lead to loss of the dental implant. The 
prevalence of peri-implantitis ranges from 16%-77.4% at patient level and 6.6%-34% at implant 
level [3, 4]. 
Although multiple factors are involved in the etiology of peri-implantitis, 
microorganisms have an essential role [5]. The submucosal biofilm associated with peri-
implantitis significantly differs from that of healthy dental implants [6, 7]). While healthy 
implants are predominantly colonized by Gram-positive facultative cocci [6, 8], Gram-negative 
mainly anaerobic species such as Porphyromonas gingivalis, Prevotella intermedia and 
Prevotella nigrescens, and Aggregatibacter actinomycetemcomitans are present in the 
submucosal biofilm associated with peri-implantitis [9, 10]. The cultivable microbiota, 
associated with peri-implantitis closely resembles microbiota associated with chronic adult 
periodontitis [9]. Microorganisms not primarily associated with periodontitis such as, Enteric 
rods Staphylococcus and Candida species have also been reported in peri-implantitis [6, 11-16].  
Evidence-based literature on treatment protocols for peri-implantitis is limited [17]. 
There is one study that reports on the clinical and microbiological effects of adjunctive systemic 
antibiotics (AB) to non-surgical treatment of peri-implantitis [18]. This study showed an 
improvement of the clinical parameters of peri-implantitis and after one year the effect still 
remained significant when compared to baseline. Since, the study had no control group, it is 
uncertain if adjunctive AB are effective to treat peri-implantitis. The additional effects of 
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systemic AB to non-surgical peri-implantitis treatment in comparison to non-surgical treatment 
alone have not been documented in literature. 
We hypothesized that non-surgical treatment with AB improves the clinical and 
microbiological parameters of peri-implantitis. The aims of this retrospective study were 1) to 
evaluate the effect of non-surgical peri-implantitis treatment on clinical and microbiological 
parameters, and 2) to relate these parameters, and use of systemic AB to non-surgical peri-
implantitis treatment response. 
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Materials and Methods 
Patient selection 
Patient data were extracted from the patient database of the Academic Centre for Dentistry, 
Amsterdam (ACTA), The Netherlands. 
Peri-implantitis was defined as presence of bleeding on probing (BoP) and/or suppuration 
on probing with pocket probing depths (PPD) of ≥5mm, and crestal bone loss ≥3mm (measured 
from the first thread of the implant to the base of the crestal bone on peri-apical radiographs). 
For patient selection, the inclusion criteria were 1) presence of at least one functional 
titanium screw type dental implant with peri-implantitis, 2) implants in function for ≥1 year and 
3) age ≥18 years. Patients were excluded if they had used systemic AB and/or non-steroidal anti-
inflammatory drug, respectively three months before and four weeks before the treatment. A 
total of 40 patient records were selected (Figure 1).  
Data collection 
The following variables were extracted from the patient records at the baseline (before the 
treatment): 1) age and gender, 2) medical condition according to the American Society of 
Anesthesiologists (ASA) classification [19], 3) number of teeth, 4) smoking and alcohol drinking 
habits, and 5) history of periodontitis. Further, the dental implant with the deepest pocket with 
BoP and bone loss was selected as target implant and the deepest pocket as target site. Data on 
implant type, location and screwed- or cement retained, keratinized or no keratinized mucosa 
was extracted.  
 The following full-mouth and target implant/site clinical parameters were collected at 
baseline and at 3 months evaluation: 1) visible plaque (yes or no), 2) BoP, 3) suppuration on 
probing, 4) PPD measured from the mucosal margin to the bottom of the probeable pocket, 5) 
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clinical attachment level (CAL, recorded from a fixed reference point using a stent) and 6) 
mucosal recession (MR=CAL-PPD). All measurements were performed at six sites per implant 
using a click probe with a standardized probing force of 0.2N (Hawe Click-Probe, Hawe Neos 
Dental, Switserland).  
 If and which systemic AB were used during the non-surgical peri-implantitis treatment 
was obtained from the patient records. Microbiological data was collected from the deepest 
implant sites at baseline and 3 months evaluation.  
 Data was made fully anonymous and this study was approved by the scientific 
committee of the ACTA, The Netherlands.  
Baseline 
Peri-implantitis patients were referred to departments of Implantology and Periodontology, 
ACTA for treatment of peri-implant infection. At the first visit, medical and dental history 
questionnaires and above described clinical parameters were recorded according to standard 
faculty procedures (DAM, PL). Subsequently, if necessary, the patients were referred to a dental 
hygienist (JvdH) for non-surgical treatment and AB were prescribed.  
Submucosal plaque was collected from the deepest peri-implant pocket using sterile 
paperpoints (Absorbent Points #5-4; Henry Schein U.K. Holdings Lrd., Southall, Middlesex, 
UB2 4AU England), placed in an Eppendorf tube with reduced transport fluid (Syed & Loesche 
1972) and stored in 4ºC until culture within 24h.  
Anaerobic culture of the putative periodontal pathogens was carried out as described 
previously [21]. Briefly, serial dilutions of the submucosal plaque samples in sterile phosphate 
buffered saline were plated on 5% horse blood agar plates (Oxoid no.2, Basingstoke, UK) 
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supplemented with hemin (5mg/l) and menadione (1mg/l). For detection of Aggregatibacter 
actinomycetemcomitans, serial dilutions were plated on trypticase soy-serumbacitracin-
vancomycin (TSBV) plates. Blood agar plates were incubated anaerobically (80%N2, 10%H2, 
and at 10%CO2) at 37˚C while TSBV plates were incubated in air in the presence of 5%CO2 for 
up to two weeks. The total number of colony forming units (CFU) was counted and converted to 
CFU/ml. The presence and proportions of Porhyromonas gingivalis, Prevotella intermedia, 
Tannerella forsythensia, Peptostreptococcus micros, Fusobactererium nucleatum, 
Campylobacter rectus and A. actinomycetemcomitans were recorded. The bacterial species were 
identified on the basis of colony morphology, microscopy, Gram-staining, anaerobic growth, the 
inability to ferment glucose, indole production as well as production of a set of metabolic 
enzymes. 
Non-surgical treatment (two to three visits) 
Before the mechanical non-surgical treatment, patients rinsed one minute with 0.12% 
chlorhexidine mouthwash (PerioAid, Dentaid, Barcelona, Spain). Implants with peri-implantitis 
were treated under local anesthesia (Ultracain-DS forte, Hoechst GmbH, Frankfurt am Main, 
Germany) using an ultrasonic device with an implant tip (EMS, Nyon, Switserland) and carbon 
fibred instruments (Universal Implant Deplaquer®; Hawe Neos Dental, Bioggio, Switserland). 
Full dental treatment was performed in case of gingivitis or periodontitis. Patients were advised 
to rinse with 0.12% chlorhexidine twice a day for four weeks. If necessary, patients received oral 
hygiene instructions every visit.  
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Evaluation 
Three months after the completion of the non-surgical treatment the above described parameters 
were measured (DAM, PL). Based on the clinical parameters, patients with limited disease 
resolution or persisting peri-implant infection, were referred for peri-implant surgery.  
Statistical analysis 
Statistical analyses were performed using SPSS software (PASW Statistics version 20.0, 
Chicago, IL, USA). Because the data was not normally distributed, Wilcoxon signed ranks tests 
were used to compare means of two continue variables and McNemar tests were applied to 
compare means of two categorical variables. Mann-Whitney U-tests were used to study 
associations of continue variables and Fisher’s exact tests for categorical variables. P-
values<0.05 were considered statistically significant. 
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Results 
Baseline characteristics of the patient cohort 
A total of 40 individuals, aged 38–76 years (mean age 61.0 years; 21 males and 19 females), 
fulfilled the inclusion criteria. The baseline characteristics of the patient cohort are summarized 
in Table 1. A total of 18 patients received systemic AB; in all cases a combination of amoxicillin 
375mg and metronidazole 250mg three times a day for 7 days. The other 22 patients did not use 
any antibiotics during the non-surgical treatment. 
 
Figure 1: Flow chart of patient selection 
 
 
 
 
 
 
 
 
 
 
N=704 N=592 
No peri-implantitis 
N=112 
N=40 
N=71 
Did not meet 
inclusion criteria 
Non-surgical treatment and AB  
N= 18 
Non-surgical treatment and no AB 
N=22 
Chapter 5 
 
119 
 
Table 1. Baseline characteristics of the patient cohort (N=40) 
Variables Subcategory N (%) 
Age (mean ±SD) 
 
 
Total 
18-39 (38.7 ±0.6) 
40-59 (52.8 ±5.2) 
60-79 (67.1 ±4.6) 
18-79 (61.0 ±10.1) 
3 (7.5) 
11 (27.5) 
26 (65.0) 
40 (100.0) 
Gender Male 
Female 
21 (52.5) 
19 (47.5) 
Dentate/Edentulous 
 
Remaining number of teeth 
N= number of teeth 
Edentulous 
Dentate 
Min. 
Max. 
(Mean ±SD) 
7 (17.5) 
33 (82.5) 
6 
28 
19.7 (±5.7) 
Medical Condition Healthy (ASA 1) 
Unhealthy (ASA = 2) 
11 (27.5) 
29 (72.5) 
Current and past smoking habits Current smoker 
Non-smoker 
             Never smoker 
          Past-smoker 
Unknown 
8 (20) 
28 (70) 
9 (22.5) 
19 (47.5) 
4 (10.0) 
Smoking habit 
 
Heavy (>15 cig/day) 
Moderate (10-15 cig/day) 
Light (1-9 cig/day 
(Mean amount ±SD) 
2 (25.0) 
2 (25.0) 
4 (50.0) 
10.2 (±6.1) 
Pack Years 
 
 
 
1-10 pack years 
11-15 pack years 
>15 pack years 
Mean years (±SD) 
4 (50.0) 
1 (12.5) 
3 (50.0) 
27.5 (±13.8) 
Alcohol (2 or more units a day) Yes 
No 
13 (32.5) 
27 (67.5) 
History of treated periodontitis Yes 
No 
Unknown 
11 (27.5) 
23 (57.5) 
6 (15.0) 
 
Clinical parameters of the target implant sites  
At baseline, no significant differences were found for the target site between the AB and 
no AB groups. At evaluation, the mean PPD of the target sites was significantly lower for both 
study groups (Table 2A, p<0.001). However, the mean PPD was significantly lower in the AB 
group (p=0.004) when compared to the no AB group. The mean CAL change was only 
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significant in the AB group (11.9mm baseline vs. 10.6mm evaluation, p=0.002). The mean MR 
was significantly higher at evaluation for both study groups (AB p=0.004; no AB p=0.04). And 
mean MR was found significantly greater in the AB group (p=0.004) than the no AB group. The 
mean BoP reduction showed a trend at evaluation in both groups (AB p=0.08; no AB p=0.025) 
when compared to baseline. The greatest PPD and MR changes were seen in deep pockets (6-
8mm) regardless of the use of additional AB.  
Also a trend was seen for less mean suppuration on probing and plaque-accumulation at 
evaluation for both groups, however not significant. Further, the mean plaque-accumulation at 
evaluation in the no AB group was significantly lower when compared to the AB group at the 
deepest sites of the target implants (p=0.02).  
Clinical parameters of the target implants 
At evaluation the mean PPD around the target implants was significantly lower for both AB and 
no AB groups (Table 2B, p=0.001 and p=0.02, respectively). The mean CAL did not differ when 
compared to baseline for both groups. The mean MR was only significantly greater for the AB 
group (5.6mm baseline vs. 6.5mm evaluation, p=0.003) and was also greater in comparison to 
the no AB group (p=0.002). Mean BoP was only significantly different in the AB group at 
evaluation (p=0.001) and showed a significantly lower mean BoP when compared to the no AB 
group (p=0.04). The mean suppuration on probing and plaque were lower at evaluation for the 
whole group (p=0.05 and p<0.001, respectively). Further, the mean plaque was also lower for the 
both AB and no AB groups (p=0.05; p=0.003, respectively).  
In the AB group 55.5% and in the no AB group 40.9% of the target implants did not need 
surgery at the evaluation.  
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Table 2. Clinical parameters of target implant site (A) and target implant (B) at baseline and 3 
month evaluation of patients treated without (N=22) or with (N=18) adjunctive antibiotics. 
Variables Baseline  
 
Evaluation  p-value 
Baseline 
vs. 
evaluation 
 p-value 
Evaluation  
AB vs. No 
AB 
A. TARGET IMPLANT SITE     
Mean PPD (mm ±SD) 
Total group 
AB* 
No AB 
 
7.4 (1.4) 
7.0 (1.5) 
7.7 (1.3) 
 
5.2 (1.4) 
4.5 (1.0) 
5.7 (1.5) 
 
<0.001 
<0.001 
<0.001 
  
 
 
0.004 
Mean CAL (mm ±SD) 
Total group 
AB 
No AB 
 
11.4 (2.0) 
11.9 (1.9) 
10.9 (1.9) 
 
10.5 (1.9) 
10.6 (1.9) 
10.4 (1.9) 
 
0.001 
0.002 
0.11 
  
 
 
0.6 
Mean MR (mm ±SD) 
Total group 
AB 
No AB 
 
4.0 (1.9) 
4.9 (2.0) 
3.2 (1.4) 
 
5.1 (2.4) 
6.1 (1.5) 
4.2 (2.7) 
 
0.001 
0.004 
0.04 
  
 
 
0.004 
Mean BoP (%) 
Total group 
AB 
No AB 
 
100 
100  
100  
 
80 
83 
77 
 
0.005 
0.08 
0.025 
  
 
 
0.6 
Mean suppuration on probing (%) 
Total group 
 
20 
 
8 
 
0.10 
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AB 
No AB 
22 
18 
6 
9 
0.08 
0.41 
 
0.7 
Mean plaque (%) 
Total group 
AB 
No AB 
 
38 
44 
32 
 
23 
39 
9 
 
0.13 
0.74 
0.06 
  
 
 
0.02 
B. TARGET IMPLANT     
Mean PPD (mm ±SEM) 
Total group 
AB 
No AB 
 
5.5 (1.2) 
5.5 (0.8) 
5.6 (1.5) 
 
4.6 (1.2) 
4.2 (0.7) 
4.9 (1.4) 
 
<0.001 
0.001 
0.02 
  
 
 
0.06 
Mean CAL (mm ±SEM) 
Total group 
AB 
No AB 
 
10.4 (2.3) 
11.1 (2.1) 
9.8 (2.4) 
 
10.3 (2.2) 
10.7 (2.0) 
9.9 (2.2) 
 
0.24 
0.14 
0.87 
  
 
 
0.22 
Mean MR (mm ±SEM) 
Total group  
AB 
No AB 
 
4.9 (2.0) 
5.6 (2.0) 
4.4 (1.7) 
 
5.5 (2.4) 
6.5 (1.9) 
4.6 (2.4) 
 
0.003 
0.003 
0.27 
  
 
 
0.002 
Mean BoP (0-6 sites) 
Total group 
AB 
No AB 
 
5.0 (1.3) 
5.1 (1.1) 
5.0 (1.5) 
 
3.6 (1.9) 
2.9 (1.8) 
4.2 (1.9) 
 
<0.001 
0.001 
0.07 
  
 
 
0.04 
Mean suppuration on probing (0-6 
sites) 
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*AB = antibiotics 
 
Microbiological parameters 
The results of the microbiological data are summarized in Table 3. All targeted bacteria except 
A. actinomycetemcomitans were found at baseline. At baseline the mean proportions and 
prevalence of target organisms were not significantly different between the AB and no AB 
group.  
No difference was found in prevalence or proportions of the targeted microorganisms in 
the AB group between baseline and evaluation. However, in the no AB group the prevalence of 
P. intermedia and P. micros was significantly lower at evaluation (p=0.004; p=0.003, 
respectively). Further, mean proportions of P. intermedia were reduced at evaluation (p=0.02).  
A trend for lower prevalence of P. gingivalis was found in the no AB group (p=0.06). 
The mean CFU/ml of anaerobic microorganisms in the target implant sites did not differ 
significantly between both groups. 
 
 
Total group 
AB 
No AB 
1.0 (1.6) 
0.8 (1.1) 
0.9 (1.9) 
0.3 (1.2) 
0.4 (1.4) 
0.3 (1.1) 
0.05 
0.23 
0.17 
 
 
0.8 
Mean plaque (0-6 sites) 
Total group 
AB 
No AB 
 
2.4 (2.3) 
2.4 (2.1) 
2.5 (2.4) 
 
0.8 (1.2) 
1.2 (1.4) 
0.6 (0.9) 
 
<0.001 
0.05 
0.003 
  
 
 
0.2 
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Table 3. Prevalence and mean proportions (±SD) of the bacterial species at the target implant 
site as detected by anaerobic culture at baseline and evaluation (N=40)  
*AB=Antibiotics; †ns = not significant
Bacterial species     
  Antibiotic group (N=18)  No antibiotic group (N=22) Evaluation 
AB* vs. 
No AB 
  Baseline Evaluation   Baseline Evaluation  
A. actinomycetemcomitans Prevalence 
N (%) 
Mean 
(±SD) 
proportion 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
ns† 
ns 
0 (0) 
0 (0) 
 0 (0) 
0 (0) 
ns 
ns 
ns 
ns 
 
P. gingivalis Prevalence 
N (%) 
Mean 
(±SD) 
proportion 
3 (17) 
1.6 (5.3) 
0 (0) 
0 (0) 
ns 
ns 
7 (32) 
7.2 (15.2) 
 4 (18) 
39.1 
(19.5) 
ns 
ns 
 
0.06 
ns 
 
P. intermedia Prevalence 
N (%) 
Mean 
(±SD) 
proportion 
5 (28) 
1.6 (4.2) 
3 (17) 
3.5 (2.3) 
ns 
ns 
10 (46) 
2.2 (5.1) 
 4 (18) 
1.8 
(2.6) 
0.004 
0.02 
 
ns 
ns 
 
T. forsythia Prevalence 
N (%) 
Mean 
(±SD) 
proportion 
8 (45) 
2.0 (4.8) 
5 (28) 
3.4 (4.1) 
ns 
ns 
9 (41) 
1.1 (2.1) 
 6 (27) 
3.5 
(3.7) 
ns 
ns 
 
ns 
ns 
P. micros Prevalence 
N (%) 
Mean 
(±SD) 
proportion 
15 (84) 
18.2 (21.7) 
11 (61) 
13.3 (15.4) 
ns 
ns 
18 (82) 
18.8 (23.2) 
 13 (59) 
9.2 
(8.8) 
0.003 
ns 
ns 
ns 
F. nucleatum Prevalence 
N (%) 
Mean 
(±SD) 
proportion 
13 (73) 
2.1 (4.7) 
13 (72) 
3.9 (8.2) 
ns 
ns 
16 (73) 
2.2 (5.2) 
 17 (77) 
1.6 
(2.8) 
ns 
ns 
 
ns 
ns 
C. rectus Prevalence 
N (%) 
Mean 
(±SD) 
proportion 
1 (6) 
4.0 (0.2) 
1 (6) 
1.38 (0) 
ns 
ns 
1 (5) 
2.0 (0) 
 3 (14) 
1.9 
(2.3) 
ns 
ns 
 
ns 
ns 
Total N of colony forming units 4.3x10^6 (6.0x10^6) 
 
ns  2.7 x106 (3.7 x106) ns  
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Discussion  
This retrospective study on the non-surgical treatment of peri-implantitis with or without the 
adjunctive use of systemic antibiotics showed improvement for mean PPD, MR and BoP on 
target site and implant level between baseline and 3 month evaluation. Furthermore, non-surgical 
treatment with AB showed a significant improvement in PPD and MR at the deepest implant 
sites, and MR and BoP at implant level when compared to non-surgical treatment alone.  
At this moment there is a need for evidence-based intervention studies on non-surgical 
peri-implantitis treatment [22]. There is one, uncontrolled cohort study that described the effect 
of systemic AB in combination with non-surgical treatment of peri-implantitis. They reported 
that combination of local debridement and systemic AB can improve clinical parameters of peri-
implantitis and be maintained for at least a year [18]. Renvert et al [23] reviewed 16 peri-
implantitis studies and concluded that mechanical debridement has no effect on peri-implantitis. 
However, they reported that BoP and PPD were reduced by mechanical debridement in 
combination systemic AB. 
 Khammissa et al [24] stated that surgical treatment will be necessary for treating peri-
implantitis, and even then total elimination of peri-implantitis cannot always be achieved. In our 
study about 50% of the patients did not need any surgery at three months evaluation. 
Thierbach et al [25] described the absence of pus as an indicator for successful non-
surgical peri-implantitis treatment. Implants showing pus on probing at baseline needed surgery 
3 months after non-surgical peri-implantitis treatment, and implants without pus on probing did 
not need surgery at evaluation. In our study we could not confirm this correlation.   
Further, in the present study P. gingivalis tended to be absent in the AB group at the 
evaluation. In line with our results, effect of amoxicilline plus metronidazole on P. gingivalis has 
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been described extensively in periodontitis [21]. Interestingly, lower prevalence of P.intermedia 
and P. micros was found only in the no AB group. Non-surgical therapy alone has previously 
been described to be effective in diminishing amounts of P. intermedia and P. micros in 
periodontitis [26]. 
Peri-implantitis is an opportunistic infection and has many features in common with 
periodontitis; both diseases are initiated by the presence of bacteria in biofilm [2]. Therefore, the 
treatment of periodontitis with mechanical debridement in combination with systemic AB has 
been applied in peri-implantitis [2].  However, recent studies using open-ended microbial 
detection techniques have revealed differences between peri-implantitis and periodontitis 
microbiota [27, 28].  
Within the limitations of the current study, the following conclusions may be drawn. 
Three months after non-surgical peri-implantitis treatment, almost 50% of the implants did not 
need surgery. No evident additional effect of the systemic antibiotics was found on the studied 
peri-implant bacterial species and total bacterial load.  
Additional AB showed a significant improvement of PPD and MR at the deepest implant 
pockets. Around the implant additional AB resulted in significant greater MR, and less BoP.  
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The success of titanium dental implants [1] has led to their increasing use in dentistry as analogs 
of roots of natural teeth. However, failure of dental implants can occur due to different causes, 
peri-implantitis being one of the major cause [2]. The incidence and prevalence of peri-
implantitis is expected to increase since an increasing number of dental implants is being 
installed each year [3]. Although peri-implant inflammation and bone loss are used as primary 
indicators of the progression of disease process, diagnostic criteria for peri-implantitis are not 
very clear [4]. Similarly, there is lack of consensus in the scientific community on the end points 
for assessing the efficacy of clinical management of peri-implantitis [5]. Consequently, no 
evidence-based treatment protocols have yet been established for peri-implantitis [6, 7]. 
Therefore, peri-implantitis constitutes a major clinical problem, which needs research to give us 
more insight into the pathogenesis of the disease process and enable us to design evidence-based 
treatment protocols for peri-implantitis.   
Scientific literature is unanimous on the polymicrobial nature of peri-implantitis, in 
which Gram-negative anaerobic bacteria dominate the peri-implant sub-mucosal microflora [8-
13]. In this thesis, we have chosen Porphyromonas gingivalis as a model periodontopathic 
bacterium, to study its interaction with host cells. Porphyromonas gingivalis is a Gram negative 
bacterium, strongly associated with peri-implantitis [13]. P. gingivalis interacts with host cells in 
a variety of ways [14] and thus may play an important role in the pathogenesis of peri-
implantitis. Host-pathogen interaction has been studied extensively in the context of periodontitis 
but studies focusing on host-pathogen interaction in peri-implantitis are scarce.  
Fibroblasts are the most common cells in the peri-implant connective tissues and they 
provide structural support to the connective tissues by synthesizing extracellular matrix and 
collagen [15, 16]. Fibroblasts also respond to microorganisms by producing inflammatory 
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mediators. Due to their slower turnover rate compared, for example, to epithelial cells, 
fibroblasts may be crucial in maintaining the inflammation associated with peri-implantitis [17]. 
Therefore, in the current thesis fibroblasts were chosen to study host-pathogen interaction in 
peri-implantitis.   
Non-capsular strains of P. gingivalis are more efficient in invading gingival fibroblasts 
P. gingivalis takes part in the pathogenesis of peri-implantitis by interacting with host cells via 
employing its various virulence factors [18]. The polysaccharide capsule of P. gingivalis is 
considered to be an important virulence factor due to its role in evasion of host immune system 
[19]. In Chapter 2 of the current thesis, we hypothesized that non-encapsulated strains of P. 
gingivalis invade gingival fibroblasts more efficiently than the encapsulated strains. It was 
shown that the isogenic non-encapsulated mutant of P. gingivalis W83 (ΔEpsC mutant) invaded 
gingival fibroblasts more efficiently compared to the encapsulated parent strain. Furthermore, we 
showed that P. gingivalis can survive inside gingival fibroblasts even in the presence of 
antibiotics (amoxicillin and metronidazole).  
Invasion of host cells is an important mechanism employed by pathogenic bacteria to 
evade host immune system. It has been reported that the encapsulated P. gingivalis strains may 
evade host defense by reducing the host immune responses [19], while the non-encapsulated 
strains may do so by invading host cells. Invasion of non-phagocytic host cells such as gingival 
fibroblasts may render P. gingivalis protection against phagocytosis by primary phagocytic cells 
(e.g. macrophages and neutrophils). Invasion and survival of P. gingivalis inside gingival 
fibroblasts can also offer protection against antibiotics. This could potentially play a role in the 
recurrence of P. gingivalis infection in peri-implantitis and periodontitis. Higher internalization 
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of known invasive bacteria such as Helicobacter pylori has been associated with antibiotic 
resistance and treatment failure [20].  
Bacterial adhesion of host cells is the first step in the invasion process. A previous study 
has reported that P. gingivalis adhere more to epithelial cells from periodontitis-susceptible 
individuals [21]. Further, non-capsular serotypes of P. gingivalis have been shown to adhere 
more to gingival pocket epithelial cells than encapsulated strains [22]. Besides the capsule, other 
P. gingivalis virulence factors such as fimbriae [23, 24] and gingipains [25] influence the host 
cell invasion process by P. gingivalis. Decreased ability of FimA deficient P. gingivalis mutants 
to invade epithelial cells has been demonstrated [23,24]. Since peri-implantitis is associated with 
multispecies biofilm, role of other oral bacteria in host cell invasion should also be taken into 
account. Fusobacterium nucleatum, another periodontopathic bacterium, has been suggested to 
facilitate invasion of P. gingivalis into epithelial and endothelial cells [26]. Most available 
studies about host cell invasion by P. gingivalis use epithelial cells and data on invasion in 
gingival fibroblasts is limited. Intracellular P. gingivalis in gingival epithelial cells and 
immortalized gingival keratinocytes can promote survival of P. gingivalis by activating a variety 
of apoptotic pathways [27, 28], and P. gingivalis infection induces regulation of distinctive P. 
gingivalis proteins and genes that could improve its survival inside epithelial cells [29-31]. 
Although the outcome of internalized P. gingivalis in gingival fibroblasts is not known, 
persistence and multiplication of P. gingivalis within epithelial cells has been demonstrated 
previously [32, 33]. The inability of commonly used antibiotics in peri-implantitis and 
periodontitis treatments to fully eliminate internalized P. gingivalis in vitro (Chapter 2), supports 
the possibility of host cells acting as reservoirs for re-infection of P. gingivalis. Furthermore, it 
can be speculated that infection caused by non-encapsulated P. gingivalis strains might be 
Chapter 6 
 
135 
 
difficult to eliminate with traditional antibiotics and might have higher chance of recurrence. 
Nevertheless, more in vivo studies are needed to confirm such an extrapolation of in vitro results 
to clinical situations. In our study, combination of metronidazole and amoxicillin was able to 
significantly reduce the internalized load of P. gingivalis. However, taking into account the 
concentrations of antibiotics that we used in our in vitro experiments and the levels of antibiotics 
in gingival fluids, the elimination of internalized P. gingivalis by antibiotics alone seems 
unlikely. Therefore, the invasion potential of P. gingivalis should be taken into account when 
prescribing antibiotic therapies for peri-implantitis and periodontitis patients.  
Peri-implant granulation tissue fibroblasts play a role in the inflammation and tissue 
breakdown associated with peri-implantitis  
In Chapter 3 an in vitro infection model was used to determine the inflammatory and matrix-
degrading responses of peri-implant granulation tissue fibroblasts (PIGFs) from peri-implantitis 
patients to P. gingivalis challenge, and compared with responses of fibroblasts from periodontitis 
patients (PGFs) and periodontally healthy controls (HGFs). Furthermore, the inflammatory 
responses of PIGFs and PGFs were determined in sustaining inflammation in peri-implantitis and 
periodontitis, respectively.  
Our results showed that at baseline, non-challenged PIGFs and PGFs are in a pro-
inflammatory state compared with HGFs. This observation is in line with previous reports [34] 
and reflects the ability of PIGFs and PGFs to maintain their activated state in culture. Further, P. 
gingivalis challenge resulted in significant induction of pro-inflammatory mediators such as 
interleukin (IL)-1β, IL-6, IL-8 and moncyte chemtactic protein (MCP)-1 in PIGFs and PGFs but 
not in HGFs. Although PIGFs have been shown to have a higher in vitro pro-inflammatory 
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response when stimulated with tumor necrosis factor (TNF)-α [35], the interaction of viable P. 
gingivalis with PIGFs has not been reported earlier. We did not find any significant difference in 
the inflammatory responses of PIGFs and PGFs to in vitro P. gingivalis challenge.  
Extracellular matrix degrading molecule matrix-metalloproteinase (MMP)-1 was 
significantly up-regulated in PIGFs and PGFs in response to P. gingivalis challenge. This up- 
regulation of MMP-1 in the absence of a significant change in the levels of tissue inhibitor of 
metalloproteinases (TIMP)-1 and transforming growth factor (TGF)-β1 indicate a role of P. 
gingivalis in matrix breakdown in peri-implantitis and periodontitis. Bordin et al. [35] have 
reported decreased secretion of TIMP-1 and TGFβ-1 at baseline by PIGFs compared to PGFs, 
although we did not find such a difference between PIGFs and PGFs. In our study, PIGFs had 
significantly higher levels of TIMP-1 compared to HGFs at baseline, and there was no 
significant difference in the expression of TGFβ-1 between the different groups of fibroblasts 
either at baseline or after P. gingivalis challenge.  
Although non-stimulated PIGFs had significantly higher levels of MMP-8 when 
compared to HGFs, P. gingivalis challenge significantly down-regulated expression of MMP-8 
by PIGFs. MMP-8 was also down-regulated in PGFs by P. gingivalis challenge, although the 
differences were not statistically significant. This is an interesting finding since MMP-8-null-
mice have been shown to be at greater risk for alveolar bone loss in P. gingivalis-induced 
periodontitis [36]. Moreover, in a P. gingivalis-induced experimental periodontitis model, MMP-
8 has been associated with a reduced expression of lipopolysaccharide-induced CXC chemokines 
(LIX/CXCL5) [37], which are important chemokines involved in neutrophil recruitment [38, 39]. 
The mechanism behind the protection offered by MMP-8 is not clear, however, MMP-8 is 
known to breakdown and deactivate certain proinflammatory mediators [40, 41] and its anti-
Chapter 6 
 
137 
 
inflammatory properties are recognized [42, 43]. P. gingivalis appears to decrease protection 
offered by MMP-8 against inflammation and alveolar bone loss via interactions with host-cells 
such as fibroblasts. On the other hand, MMP-8 is primarily produced by neutrophils and P. 
gingivalis appears to be a weak inducer of MMP-8 even in neutrophils [44].  
Further, we demonstrated that after removal of P. gingivalis, PIGFs remained in a pro-
inflammatory state compared to PGFs. This sustained pro-inflammatory response by PIGFs 
highlights their importance in the pathogenesis of peri-implantitis. This data suggests that 
inflammation and matrix-breakdown may continue in peri-implantitis even after removing the 
source of infection.  
Animal studies have revealed important differences between experimentally induced 
peri-implantitis and periodontitis lesions. Compared to lesions around natural teeth, more 
pronounced inflammation and greater size of inflammatory infiltrate in peri-implantitis lesions 
have been reported [45, 46]. Clinical and radiographic signs of tissue destruction also tend to be 
more pronounced in peri-implantitis lesions compared to lesions around teeth [45]. Our results 
support the idea that disease progression and tissue destruction in peri-implantitis might follow a 
different course than in periodontitis. Furthermore, sustaining proinflammatory response of 
PIGFs to infectious stimuli may play a role in inflammation and tissue destruction in peri-
implantitis. However, it is important to acknowledge that other factors such as; the difficulty to 
decontaminate the implant surface, absence of a physical barrier in the form of periodontal 
ligament around implants, decreased vascularity of the peri-implant connective tissues [47], 
presence of a foreign body in the form of dental implant and interaction of peri-implant tissue 
with the implant material are also important in the progression of inflammation and tissue 
destruction in peri-implantitis.  
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Titanium wear debris can influence host-bacterial interaction in peri-implantitis 
Titanium (Ti) is the most widely used material for dental implants due to its excellent 
biocompatibility with living tissues [48]. Ti was previously thought to be an inert material, 
however, Ti ions and particles have been found in different layers of peri-implant connective 
tissues [49] and recently interest is growing in the immunological responses of tissues to Ti wear 
debris study [50-53]. Studies focusing on the role of Ti in immune responses in peri-implantitis 
are limited. Moreover, a role of Ti in the interaction between P. gingivalis and fibroblasts has not 
been reported previously. 
In Chapter 4 we investigated the influence of Ti microparticles on fibroblast-P. 
gingivalis interaction in peri-implantitis in vitro. Our results suggest that at high concentrations, 
Ti significantly reduces the viability of PIGFs in vitro. Sub-toxic concentrations of Ti and a 
challenge with P. gingivalis alone elicited pro-inflammatory reactions in PIGFs. Interestingly, a 
combined challenge with Ti-particles and P. gingivalis induced a greater increase in the 
expression of TNF-α and MCP-1 when compared to a challenge with P. gingivalis alone. This 
may imply that microorganisms such as P. gingivalis in combination with Ti-wear debris are 
capable of enhancing inflammation in the peri-implant tissues.  
The potential of Ti to elicit inflammatory immune reactions in various host cell types has 
been reported in several in vitro studies [54-56]. Limited evidence from clinical studies shows 
that elevated levels of inflammatory cytokines such as TNF-α and IL-1β are found in the peri-
implant sulcular fluid, in spite of minimal bacterial challenge [57, 58]. Inflammatory host 
response to external stimuli starts with the triggering of pattern recognition receptors (PRR) such 
as Toll-like receptors (TLRs). TLRs may function as receptors for microbial organisms as well 
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as endogenous ligands [59, 60] and increased expression of TLRs, including TLR4 and TLR9, 
have been found in the interface membrane around loosening total hip replacement implants, 
where Ti particles may exist [61]. Recently it has also been shown that Ti ions have biological 
and/or adverse effects on the expressions of receptor activator of nuclear factor kappa beta (NF-
κB) ligand (RANKL) and osteoprotegerin (OPG) in osteoblastic cells [62]. Imbalances in the 
levels of RANKL-RANK and OPG are important in pathologic bone resorption as these factors 
are essential for the differentiation and development of osteoclasts [63]. Therefore, tissue 
reactions to Ti may influence the rate of bone resorption around dental implants.  
A recent study reported that mRNA levels of TNF-α, IL-1β, and IL-6 increased after 
phagosytosis of Ti particles coated with LPS in comparison to Ti particles without LPS coating 
[64]. Another study showed that TLR2 and TLR4 contribute to the biological activity of titanium 
particles with adherent bacterial debris [65]. These studies further support our results that Ti and 
microbes may act in concert in the pathogenesis of peri-implantitis.  
Non-surgical peri-implantitis treatment is effective in improving clinical parameters of 
peri-implantitis 
Chapter 5 describes a retrospective study, in which we evaluated the effects of non-surgical 
peri-implantitis treatment on the clinical and microbiological parameters of peri-implantitis. In 
addition, clinical and microbiological parameters as well as use of systemic antibiotics were 
related to non-surgical peri-implantitis treatment response.  
 Our study showed that regardless of systemic antibiotics use (combination of amoxicillin 
375mg and metronidazole 250mg three times a day for 7 days), non-surgical treatment of peri-
implantitis was effective in improving clinical parameters such as bleeding on probing (BoP), 
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mucosal recession (MR) and peri-implant pocket probing depth (PPD) at three months evaluation 
when compared to baseline. Interestingly, adjunctive use of systemic antibiotics showed 
additional value in reducing BoP and improving MR compared to no use of antibiotics. The 
prevalence and proportions of the targeted peri-implant sub-mucosal microbiota were not 
significantly affected by the use of systemic antibiotics. No differences were found in the 
prevalence or proportions of the targeted microorganisms in the antibiotic group between 
baseline and evaluation. However, in the no antibiotic group, lower prevalences of P. intermedia, 
P. micros and P. gingivalis were found at evaluation. All diagnosed bacteria were found at 
baseline, except Aggregatibacter actinomycetemcomitans and at evaluation, Porphyromonas 
gingivalis was not detected in the AB group. 56 % of the implants in the antibiotic group and 
41% of the implants in the no antibiotic group needed surgical treatment.  
Treatment of peri-implantitis is aimed to decrease the load of submucosal bacteria by 
disinfecting the implant surface, and restoring the soft tissue around implant. While mechanical 
debridement alone is effective in reducing the peri-implant inflammation and bacterial loads, 
studies report that many implants still need surgical interventions in order to halt the progress of 
peri-implantitis [66]. Therefore, many different types of non-surgical and surgical methods have 
been proposed for the management of peri-implantitis [66, 67]. Surface decontamination of the 
affected implant is mainly carried out by scaling and debridement of the implant surface, alone 
or combined with the use of local or systemic antibacterial agents [67]. The use of lasers [68] and 
photodynamic therapy [69] have also been proposed for the surface decontamination of dental 
implants, although the evidence for the their effectiveness is still preliminary.  
Studies on use of systemic antibiotics in the treatment of peri-implantitis are scarce [70, 
71]. There is only one, uncontrolled study [71] that describes the effects of non-surgical peri-
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implantitis treatment along with the use of systemic antibiotics (Ornidazole 1000mg for 10 days) 
on the clinical and microbiological parameters of the affected implants. The study reports 
significant reduction of PPD and BoP as a result of the intervention, which is in line with the 
findings of our study. In contrast to our study, the study by Mombelli et al. [71] also reports 
significant suppression of the submucosal anaerobic microflora in the 12 months observation 
period. This lack of consensus might be due to the different types of systemic antibiotics used in 
both the studies. 
Although use of systemic antibiotics has been associated with improvement of clinical 
signs of peri-implantitis, the evidence is still inconclusive regarding the effects of systemic 
antibiotics on the microbiota associated with peri-implantitis. It should also be noted that most 
studies make use of traditional approaches to microbiological sampling and detection. It is 
possible that the optimal bacteriological sampling method has not been established yet [72]. In 
addition, many species in the oral cavity are found and not yet identified [73]. In vitro studies 
have also demonstrated that the surface texture and composition of dental implants can 
significantly influence the associated microbiota [74, 75], influencing the effect of non-surgical 
treatment.  
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P. gingivalis is a Gram-negative, anaerobic bacterium associated with peri-implantitis. P. 
gingivalis induces inflammatory and immunological responses in host cells which are aimed at 
eliminating the infection and restoring tissue homeostasis. In susceptible hosts, interaction of P. 
gingivalis with host cells may result in aberrant inflammatory responses which lead to 
inflammation and tissue destruction around the dental implant. Titanium dental implants under 
occlusal stresses can undergo corrosion and wear. As a result, titanium wear particles (TiO2) are 
present in the peri-implant soft tissues. However, influence of TiO2-particles to host-pathogen 
interaction in peri-implantitis is largely unknown.  Fibroblasts are important host cells, as they 
not only provide structural support to the implant but also take part in inflammatory host 
reactions to external stimuli. In the current thesis, we aimed to study the role of interaction 
between fibroblasts, viable P. gingivalis and titanium particles in the pathogenesis of peri-
implantitis. In addition, effects of non-surgical peri-implantitis treatment on the clinical and 
microbiological parameters were studied.  
 We found that viable P. gingivalis can invade gingival fibroblasts in vitro and the non-
encapsulated P. gingivalis is more efficient in invading gingival fibroblasts. It has been 
suggested that the predominant mode of encapsulated P. gingivalis strains to evade host defenses 
is blunting the host immune responses; the non-encapsulated strains may evade the host defenses 
by invading host cells. Interestingly, even high concentrations of antibiotics were not able to 
completely eradicate the P. gingivalis internalized into gingival fibroblasts. This may imply that 
internalization of P. gingivalis into fibroblasts protects it from antibiotics to which it is otherwise 
susceptible. We speculate that, internalized P. gingivalis may potentially act as a reservoir for 
future re-infection of peri-implantitis and periodontitis sites. Therefore, internalization of P. 
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gingivalis into gingival fibroblasts may contribute significantly to the pathogenesis of peri-
implantitis.   
We also studied gene expression and protein production of selected pro-inflammatory 
cytokines and matrix-metalloproteinases in P. gingivalis – fibroblast interaction. Peri-implant 
granulation tissue fibroblasts from peri-implantitis patients (PIGFs) were challenged with viable 
P. gingivalis and compared with gingival fibroblasts from periodontitis patients (PGFs) and 
periodontally healthy controls (HGFs). Our results indicate that before the P. gingivalis 
challenge, interleukin (IL)-1β, IL-8 and monocyte chemotactic protein (MCP)-1 are expressed at 
higher levels in PIGFs and PGFs compared to HGFs. After the P. gingivalis challenge, 
significant up-regulation was observed in the gene expression of IL-1β, IL-6, IL-8, MCP-1 and 
MMP-1 in PIGFs and PGFs but not in HGFs. Interestingly, the P. gingivalis challenge down-
regulated MMP-8 expression in PIGFs. In addition, PIGFs sustained higher induction of IL-1β, 
MCP-1 and MMP-1compared to PGFs, after the removal of P. gingivalis. Our results indicate 
that non-challenged fibroblasts from peri-implantitis and periodontitis lesions are in a pro-
inflammatory state and give higher pro-inflammatory responses when challenged with P. 
gingivalis. In addition, PIGFs may play a role in the pathogenesis of peri-implantitis by 
sustaining inflammation in the peri-implant tissues. 
 We studied the effects of TiO2-particles alone and in combination with P. gingivalis on 
the inflammatory reactions in PIGFs. Despite the biocompatibility properties of titanium, our 
results suggest that TiO2-particles can induce pro-inflammatory reactions in PIGFs. A challenge 
with P. gingivalis alone elicited pro-inflammatory reactions in PIGFs. Interestingly, a combined 
challenge with TiO2-particles and P. gingivalis caused a stronger increase in the gene and protein 
expression of TNF-α and MCP-1 when compared to a challenge with P. gingivalis alone. Our 
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findings may implicate that P. gingivalis infection in combination with the presence of titanium 
wear particles has the potential to enhance inflammation associated with peri-implantitis.  
 Peri-implantitis is treated non-surgically as well as surgically in contemporary dental 
practice. Non-surgical treatment of peri-implantitis mainly consists of mechanical debridement 
of the implant surface with/without the use of local and/or systemic antibacterial agents. 
However, the effects of non-surgical treatment of peri-implantitis on the clinical outcome have 
not been thoroughly studied. We retrospectively studied the effects of non-surgical peri-
implantitis treatment with or without the use of systemic antibiotics, on the clinical and 
microbiological parameters of peri-implantitis. Regardless of systemic antibiotics use, non-
surgical peri-implantitis treatment was effective in improving clinical parameters such as 
bleeding on probing (BoP), mucosal recession (MR) and peri-implant pocket probing depth 
(PPD), at three months evaluation when compared to baseline. Use of systemic antibiotics 
showed additional value in improving BoP and MR around the implants. However, use of 
systemic antibiotics did not significantly affect the presence or proportions of target bacteria in 
submucosal plaque.  47.5% implants did not need surgery three months after non-surgical peri-
implantitis treatment, regardless of antibiotic use. These findings indicate that non-surgical peri-
implantitis treatment is effective in reducing peri-implant inflammation.  
In conclusion, research presented in the current thesis indicates that non-encapsulated P. 
gingivalis can evade host defenses by intersnalization into gingival fibroblasts and that 
internalized P. gingivalis can survive antibiotic treatment in vitro. Further, P. gingivalis may 
enhance and sustain inflammation and facilitate matrix breakdown by means of interaction with 
fibroblasts from peri-implantitis and periodontitis lesions. Moreover, peri-implantitis fibroblasts 
react to titanium wear particles by releasing pro-inflammatory cytokines and this effect is 
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increased in presence of P. gingivalis. Therefore, P. gingivalis-fibroblast-titanium interaction 
may significantly contribute to the pathogenesis of peri-implantitis.  Lastly, non-surgical 
treatment of peri-implantitis is effective in reducing inflammation in peri-implantitis.  
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Porphyromonas gingivalis is een Gram-negatieve anaerobe bacterie die geassocieerd is met 
peri-implantitis.  In geval van infectie reageren gastheercellen normaalgesproken op P. 
gingivalis met een ontstekingsrespons die tot doel heeft de infectie te elimineren, en normale 
weefselhomeostase te herstellen. In een gevoelige gastheer leidt de interactie tussen P. 
gingivalis en gastheercellen echter tot een verstoorde  ontstekingsrespons, wat resulteert in 
peri-implantitis; overmatige ontsteking en weefselafbraak rondom een tandimplantaat.   
Tandimplantaten zijn door kauwkrachten onderhevig aan corrosie en slijtage. Hierdoor 
kunnen er kleine titaniumdeeltjes (TiO2) vrijkomen in de zachte weefsels rondom het 
implantaat.  
 Tot nu toe is er weinig bekend over de invloed die zulke titanium deeltjes bij peri-
implantitis kunnen hebben op de reactie van gastheercellen op orale pathogenen zoals P. 
gingivalis. Gingivale fibroblasten zijn gastheercellen in de weefsels rondom het implantaat 
die een actieve rol spelen bij de ontstekingsrespons op externe stimuli. Daarnaast leveren 
deze fibroblasten structurele steun aan het tandimplantaat. Het onderzoek in dit proefschrift 
had tot doel om in vitro te bestuderen hoe de interactie tussen fibroblasten, levende P. 
gingivalis, en titanium deeltjes bijdraagt aan de het pathogenese van peri-implantitis. 
Daarnaast werd onderzocht of een non-chirurgische behandeling effectief bijdraagt aan het 
remmen van ontsteking, en verbeteren van klinische en microbiële parameters bij peri-
implantitis. 
 Uit het onderzoek bleek ten eerste dat P. gingivalis gingiva fibroblasten kan 
binnendringen. Ongekapselde P. gingivalis waren daarin efficiënter dan gekapselde P. 
gingivalis. Gekapselde P. gingivalis ontwijken waarschijnlijk het immuunsysteem van de 
gastheer voornamelijk vanwege het kapsel, dat herkenning door de gastheer voorkomt. 
Ongekapselde stammen zouden wellicht het immuunsysteem kunnen ontwijken door in 
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gastheercellen binnen te dringen. In dit opzicht is het interessant dat zelfs hoge concentraties 
antibiotica niet in staat waren om geïnternaliseerde P. gingivalis volledig te doden. Door 
binnen te dringen in fibroblasten wordt P. gingivalis dus beschermd tegen antibiotica 
waarvoor deze bacterie normaalgesproken gevoelig zou zijn. Het is mogelijk dat P. 
gingivalis, geïnternaliseerd in fibroblasten,  dient als een reservoir van waaruit her-infectie 
van de weefsels rondom implantaten of tanden met P. gingivalis kan plaatsvinden. Het 
binnendringen van gingivale fibroblasten door P. gingivalis kan hierdoor een belangrijke rol 
spelen bij de pathogenese van peri-implantitis.  
 Hierna werd de genexpressie en eiwitproductie van een aantal pro-inflammatoire 
cytokines en matrix-metalloproteinasen bij de interactie tussen P. gingivalis en fibroblasten 
bepaald. Hiertoe werden fibroblasten verworven uit granulatieweefsel rondom 
tandimplantaten van peri-implantitis patiënten (PIGFs), en vervolgens in vitro gestimuleerd 
met levende P. gingivalis. De reacties van deze peri-implantitis fibroblasten op P. gingivalis 
werden vergeleken met fibroblasten van parodontitis patiënten (PGFs) en van gezonde 
donoren (HGFs). De resultaten laten zien dat in afwezigheid van P. gingivalis de cytokines 
interleukine (IL)-1β, IL-8, en monocyte chemotactic protein (MCP)-1 meer tot expressie 
kwamen in peri-implantitis en parodontitis fibroblasten, dan in gezonde fibroblasten. Een 
stimulus met P. gingivalis leidde vervolgens alleen in peri-implantitis en parodontitis 
fibroblasten tot een verhoging van de expressie van de cytokines IL-1β, IL-6, IL-8, MCP-1, 
en MMP-1, maar niet in gezonde fibroblasten. Alleen in peri-implantitis fibroblasten bleek 
verder de expressie van MMP-8 te worden verlaagd door een stimulus met P. gingivalis. 
Bovendien bleven peri-implantitis fibroblasten gedurende langere tijd een verhoogde 
expressie van IL-1β, MCP-1 en MMP-1 behouden, ook nadat de stimulus met P. gingivalis 
was beëindigd. Dit wijst erop dat peri-implantitis en parodontitis fibroblasten vergeleken met 
gezonde fibroblasten een meer pro-inflammatoir profiel hebben, en heviger reageren op een 
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stimulus met P. gingivalis. Peri-implantitis fibroblasten kunnen daarnaast door het aanhouden 
van een ontstekingsreactie een belangrijke rol spelen bij de pathogenese van peri-implantitis. 
Vervolgens werden de mogelijke effecten van titaniumdeeltjes, en van titaniumdeeltjes in 
combinatie met P. gingivalis, op ontstekingsreacties in peri-implantitis fibroblasten 
onderzocht. Hoewel titanium over  het algemeen een biocompatibel materiaal is, blijkt uit 
onze resultaten dat titanium deeltjes ontstekingsreacties opwekken in peri-implantitis. 
Wanneer peri-implantitis fibroblasten werden gestimuleerd met zowel titanium deeltjes als P. 
gingivalis, leidde dit tot een nog sterker verhoogde expressie van de cytokines TNFα en 
MCP-1, dan bij P. gingivalis alleen. Dit impliceert dat de aanwezigheid van titanium afbraak 
deeltjes en van P. gingivalis de ontsteking bij peri-implantitis kan verhevigen. 
Peri-implantitis kan zowel chirurgisch als non-chirurgisch worden behandeld.  Een non-
chirurgische behandeling bestaat voornamelijk uit het mechanisch reinigen van het 
implantaatoppervlak, eventueel in combinatie met lokale of systemische antibiotica. Het is 
echter nog onvoldoende bekend wat het klinische resultaat van een dergelijke behandeling is 
bij peri-implantitis. Daarom hebben wij, retrospectief, de effecten van een non-chirurgische 
behandeling, al dan niet in combinatie met lokaal of systemisch antibioticagebruik,  op 
klinische en microbiële parameters bij peri-implantitis  bestudeerd. Hieruit bleek dat een non-
chirurgische behandeling na 3 maanden een positief effect had op een aantal klinische 
parameters, zoals bloeding bij sonderen, mucosale recessie, en pocket diepte rondom het 
implantaat. Het gebruik van systemische antibiotica leidde daarbij nog tot een extra reductie 
van de bloeding, pocket diepte en mucosale recessie rondom implantaten. Het gebruik van 
antibiotica had echter geen significant effect op de proporties van peri-implantitis 
geassocieerde bacteriën in sub-mucosale plaque. Bij 47,5% van de implantaten was het na 3 
maanden niet nodig om ook nog een chirurgische behandeling uit te voeren. 
Antibioticagebruik speelde daarbij geen rol. Deze resultaten geven aan dat een non-
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chirurgische peri-implantitis behandeling effectief is om ontsteking rondom een implantaat te 
verminderen. 
Uit het onderzoek dat is gepresenteerd in dit proefschrift kan worden geconcludeerd 
dat ongekapselde P. gingivalis de defensiemechanismen van de gastheer kan ontwijken door 
binnen te dringen in fibroblasten, en dat P. gingivalis daardoor in vitro een 
antibioticabehandeling kan overleven. Ook kan de interactie tussen P. gingivalis en 
fibroblasten in een peri-implantitis of parodontitis laesie leiden tot aanhoudende ontsteking, 
en weefselafbraak. Bovendien reageren peri-implantitis fibroblasten ook op titanium debris 
deeltjes met het produceren van pro-inflammatoire cytokines. Deze reactie wordt versterkt 
door de gecombineerde aanwezigheid van titanium en P. gingivalis. Daarom is de interactie 
tussen P. gingivalis, fibroblasten, en titanium deeltjes van significant belang voor de 
ontwikkeling van ontsteking bij peri-implantitis.  Een non-chirurgische peri-implantitis 
behandeling  kan effectief zijn bij het reduceren van deze ontsteking. 
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